Raras
Buscar doenças, sintomas, genes...
Alteração da absorção e transporte de carboidratos
ORPHA:309001CID-11 · 5C61DOENÇA RARA

Minerrais essencias são micronutrientes inorgânicos indispensáveis ao funcionamento do corpo humano. Participam de reações bioquímicas, equilíbrio hidroeletrolítico, formação de tecidos, transmissão nervosa e respostas imunológicas. Eles se dividem em:Macrominerais: necessários em maior quantidade. Microminerais: requeridos em pequenas quantidades.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença rara com manifestações neurológicas (apraxia da fala, apneia central do sono, crises epilépticas), alterações torácicas e faciais, e problemas de coagulação. Associada a mutações em genes como PIDD1 e EXOSC3, impactando a absorção e transporte de carboidratos.

🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
91 sintomas
😀
Face
50 sintomas
🦴
Ossos e articulações
28 sintomas
🫃
Digestivo
25 sintomas
📏
Crescimento
25 sintomas
👁️
Olhos
24 sintomas

+ 224 sintomas em outras categorias

Características mais comuns

Tórax estreito
Sobrancelha larga
Hiperintensidades da substância branca periventricular
Hirsutismo dorsal
Apraxia da fala
Apneia central do sono
541sintomas
Sem dados (541)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 541 características clínicas mais associadas, ordenadas por frequência.

Tórax estreitoNarrow chest
Sobrancelha largaBroad eyebrow
Hiperintensidades da substância branca periventricularPeriventricular white matter hyperintensities
Hirsutismo dorsalDorsal hirsutism
Apraxia da falaSpeech apraxia

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa5
Últimos 10 anos200publicações
Pico202450 papers
Linha do tempo
2021Hoje · 2026📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

72 genes identificados com associação a esta condição.

PIDD1PIDD1 alternative open reading frame proteinDisease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (1)
TP53 Regulates Transcription of Caspase Activators and Caspases
EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
43.9 TPM
Tireoide
37.0 TPM
Cérebro - Hemisfério cerebelar
36.7 TPM
Testículo
34.8 TPM
Próstata
33.5 TPM
OUTRAS DOENÇAS (1)
intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly
HGNC:HGNC:16491UniProt:C0HMD6
EXOSC3Exosome complex component RRP40Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defe

LOCALIZAÇÃO

CytoplasmNucleus, nucleolusNucleus

VIAS BIOLÓGICAS (5)
mRNA decay by 3' to 5' exoribonucleaseATF4 activates genes in response to endoplasmic reticulum stressKSRP (KHSRP) binds and destabilizes mRNAButyrate Response Factor 1 (BRF1) binds and destabilizes mRNATristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 1B

A severe autosomal recessive neurologic disorder characterized by a combination of cerebellar and spinal motor neuron degeneration beginning at birth. There is diffuse muscle weakness, progressive microcephaly, global developmental delay, and brainstem involvement.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
30.1 TPM
Testículo
28.1 TPM
Fibroblastos
21.2 TPM
Cervix Endocervix
16.4 TPM
Ovário
15.4 TPM
OUTRAS DOENÇAS (2)
pontocerebellar hypoplasia type 1Bpontocerebellar hypoplasia type 1
HGNC:17944UniProt:Q9NQT5
ZC3H14Zinc finger CCCH domain-containing protein 14Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

RNA-binding protein involved in the biogenesis of circular RNAs (circRNAs), which are produced by back-splicing circularization of pre-mRNAs (PubMed:39461343). Acts by binding to both exon-intron boundary and 3'-UTR of pre-mRNAs to promote circRNA biogenesis through dimerization and the association with the spliceosome (PubMed:39461343). Required for spermatogenesis via involvement in circRNA biogenesis (PubMed:39461343). Regulates the pre-mRNA processing of ATP5MC1; preventing its degradation (

LOCALIZAÇÃO

Nucleus speckleCytoplasm

MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 56

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
38.0 TPM
Cérebro - Hemisfério cerebelar
14.7 TPM
Cerebelo
14.1 TPM
Ovário
13.3 TPM
Útero
12.0 TPM
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 56autosomal recessive non-syndromic intellectual disability
HGNC:20509UniProt:Q6PJT7
VRK1Serine/threonine-protein kinase VRK1Candidate gene tested inTolerante
FUNÇÃO

Serine/threonine kinase involved in the regulation of key cellular processes including the cell cycle, nuclear condensation, transcription regulation, and DNA damage response (PubMed:14645249, PubMed:18617507, PubMed:19103756, PubMed:33076429). Controls chromatin organization and remodeling by mediating phosphorylation of histone H3 on 'Thr-4' and histone H2AX (H2aXT4ph) (PubMed:31527692, PubMed:37179361). It also phosphorylates KAT5 in response to DNA damage, promoting KAT5 association with chr

LOCALIZAÇÃO

NucleusCytoplasmNucleus, Cajal body

VIAS BIOLÓGICAS (1)
Initiation of Nuclear Envelope (NE) Reformation
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 1A

A form of pontocerebellar hypoplasia, a disorder characterized by structural defects of the pons and cerebellum, evident upon brain imaging. PCH1A is an autosomal recessive form characterized by an abnormally small cerebellum and brainstem, central and peripheral motor dysfunction from birth, gliosis and spinal cord anterior horn cells degeneration resembling infantile spinal muscular atrophy. Additional features include muscle hypotonia, congenital contractures and respiratory insufficiency that is evident at birth.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
60.6 TPM
Testículo
41.3 TPM
Baço
13.9 TPM
Fibroblastos
12.9 TPM
Fallopian Tube
9.9 TPM
OUTRAS DOENÇAS (4)
neuronopathy, distal hereditary motor, autosomal recessive 10pontocerebellar hypoplasia type 1Apontocerebellar hypoplasia type 1microcephaly-complex motor and sensory axonal neuropathy syndrome
HGNC:12718UniProt:Q99986
SISucrase-isomaltase, intestinalDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays an important role in the final stage of carbohydrate digestion. Isomaltase activity is specific for both alpha-1,4- and alpha-1,6-oligosaccharides

LOCALIZAÇÃO

Apical cell membrane

VIAS BIOLÓGICAS (2)
Digestion of dietary carbohydrateIntestinal saccharidase deficiencies
MECANISMO DE DOENÇA

Congenital sucrase-isomaltase deficiency

Autosomal recessive intestinal disorder that is clinically characterized by fermentative diarrhea, abdominal pain, and cramps upon ingestion of sugar. The symptoms are the consequence of absent or drastically reduced enzymatic activities of sucrase and isomaltase. The prevalence of CSID is 0.02 % in individuals of European descent and appears to be much higher in Greenland, Alaskan, and Canadian native people. CSID arises due to post-translational perturbations in the intracellular transport, polarized sorting, aberrant processing, and defective function of SI.

EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
80.9 TPM
Testículo
3.8 TPM
Cólon transverso
3.3 TPM
Próstata
0.1 TPM
Cólon sigmoide
0.0 TPM
OUTRAS DOENÇAS (1)
congenital sucrase-isomaltase deficiency
HGNC:10856UniProt:P14410
AIMP1Aminoacyl tRNA synthase complex-interacting multifunctional protein 1Candidate gene tested inTolerante
FUNÇÃO

Non-catalytic component of the multisynthase complex. Stimulates the catalytic activity of cytoplasmic arginyl-tRNA synthase (PubMed:10358004). Binds tRNA. Possesses inflammatory cytokine activity (PubMed:11306575). Negatively regulates TGF-beta signaling through stabilization of SMURF2 by binding to SMURF2 and inhibiting its SMAD7-mediated degradation (By similarity). Involved in glucose homeostasis through induction of glucagon secretion at low glucose levels (By similarity). Promotes dermal f

LOCALIZAÇÃO

NucleusCytoplasm, cytosolSecretedEndoplasmic reticulumGolgi apparatus

VIAS BIOLÓGICAS (3)
Selenoamino acid metabolismCytosolic tRNA aminoacylationTranscriptional and post-translational regulation of MITF-M expression and activity
MECANISMO DE DOENÇA

Leukodystrophy, hypomyelinating, 3

A severe autosomal recessive hypomyelinating leukodystrophy characterized by early infantile onset of global developmental delay, lack of development, lack of speech acquisition, and peripheral spasticity associated with decreased myelination in the central nervous system.

OUTRAS DOENÇAS (2)
hypomyelinating leukodystrophy 3autosomal recessive non-syndromic intellectual disability
HGNC:10648UniProt:Q12904
ST3GAL3CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferaseDisease-causing germline mutation(s) inModerado
FUNÇÃO

Catalyzes the formation of the NeuAc-alpha-2,3-Gal-beta-1,4-GlcNAc-, NeuAc-alpha-2,3-Gal-beta-1,3-GlcNAc- and NeuAc-alpha-2,3-Gal-beta-1,3-GalNAc- sequences found in terminal carbohydrate groups of glycoproteins and glycolipids. The highest activity is toward Gal-beta-1,3-GlcNAc and the lowest toward Gal-beta-1,3-GalNAc

LOCALIZAÇÃO

Golgi apparatus, Golgi stack membraneSecreted

VIAS BIOLÓGICAS (9)
Pre-NOTCH Processing in GolgiMaturation of protein 3aMaturation of protein 3aMaturation of spike proteinSialic acid metabolism
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 12

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
43.3 TPM
Músculo esquelético
28.4 TPM
Cerebelo
22.7 TPM
Córtex cerebral
22.6 TPM
Nervo tibial
21.6 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 12developmental and epileptic encephalopathy, 15
HGNC:10866UniProt:Q11203
NSUN2RNA cytosine C(5)-methyltransferase NSUN2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

RNA cytosine C(5)-methyltransferase that methylates cytosine to 5-methylcytosine (m5C) in various RNAs, such as tRNAs, mRNAs and some long non-coding RNAs (lncRNAs) (PubMed:17071714, PubMed:22995836, PubMed:31199786, PubMed:31358969). Involved in various processes, such as epidermal stem cell differentiation, testis differentiation and maternal to zygotic transition during early development: acts by increasing protein synthesis; cytosine C(5)-methylation promoting tRNA stability and preventing m

LOCALIZAÇÃO

Nucleus, nucleolusCytoplasmMitochondrionCytoplasm, cytoskeleton, spindleSecreted, extracellular exosome

VIAS BIOLÓGICAS (1)
tRNA modification in the nucleus and cytosol
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 5

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
100.6 TPM
Fibroblastos
71.2 TPM
Útero
56.4 TPM
Fallopian Tube
54.5 TPM
Nervo tibial
54.3 TPM
OUTRAS DOENÇAS (3)
intellectual disability, autosomal recessive 5Dubowitz syndromeautosomal recessive non-syndromic intellectual disability
HGNC:25994UniProt:Q08J23
EDC3Enhancer of mRNA-decapping protein 3Candidate gene tested inTolerante
FUNÇÃO

Binds single-stranded RNA. Involved in the process of mRNA degradation and in the positive regulation of mRNA decapping. May play a role in spermiogenesis and oogenesis

LOCALIZAÇÃO

Cytoplasm, P-body

VIAS BIOLÓGICAS (1)
mRNA decay by 5' to 3' exoribonuclease
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 50

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT50 patients show mild intellectual disability and microcephaly.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
44.8 TPM
Linfócitos
28.5 TPM
Útero
24.8 TPM
Cerebelo
24.6 TPM
Ovário
24.4 TPM
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 50autosomal recessive non-syndromic intellectual disability
HGNC:26114UniProt:Q96F86
TUSC3Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts as accessory component of the N-oligosaccharyl transferase (OST) complex which catalyzes the transfer of a high mannose oligosaccharide from a lipid-linked oligosaccharide donor to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains. Involved in N-glycosylation of STT3B-dependent substrates. Specifically required for the glycosylation of a subset of acceptor sites that are near cysteine residues; in this function seems to act redundantly with MAGT1. I

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (4)
Maturation of spike proteinAsparagine N-linked glycosylationPD-L1(CD274) glycosylation and translocation to plasma membraneMaturation of DENV proteins
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 7

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
74.8 TPM
Fibroblastos
62.9 TPM
Glândula adrenal
51.9 TPM
Ovário
48.4 TPM
Cérebro - Hemisfério cerebelar
47.4 TPM
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 7autosomal recessive non-syndromic intellectual disability
HGNC:30242UniProt:Q13454
TNIKTRAF2 and NCK-interacting protein kinaseDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Serine/threonine kinase that acts as an essential activator of the Wnt signaling pathway. Recruited to promoters of Wnt target genes and required to activate their expression. May act by phosphorylating TCF4/TCF7L2. Appears to act upstream of the JUN N-terminal pathway. May play a role in the response to environmental stress. Part of a signaling complex composed of NEDD4, RAP2A and TNIK which regulates neuronal dendrite extension and arborization during development. More generally, it may play a

LOCALIZAÇÃO

NucleusCytoplasmRecycling endosomeCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (1)
Oxidative Stress Induced Senescence
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 54

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT54 patients manifest intellectual disability, delayed speech and hyperactivity.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
32.1 TPM
Brain Caudate basal ganglia
23.3 TPM
Testículo
20.6 TPM
Brain Nucleus accumbens basal ganglia
19.7 TPM
Córtex cerebral
16.8 TPM
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 54autosomal recessive non-syndromic intellectual disability
HGNC:30765UniProt:Q9UKE5
ALKBH8tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ALKBH8Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the methylation of 5-carboxymethyl uridine to 5-methylcarboxymethyl uridine at the wobble position of the anticodon loop in tRNA via its methyltransferase domain (PubMed:20123966, PubMed:20308323, PubMed:31079898). Catalyzes the last step in the formation of 5-methylcarboxymethyl uridine at the wobble position of the anticodon loop in target tRNA (PubMed:20123966, PubMed:20308323). Has a preference for tRNA(Arg) and tRNA(Glu), and does not bind tRNA(Lys) (PubMed:20308323). Binds tRNA a

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
tRNA modification in the nucleus and cytosol
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 71

A form of intellectual disability, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT71 features include impaired intellectual development, global developmental delay, mildly delayed walking, poor language, seizures in the first years of life, and behavioral abnormalities.

OUTRAS DOENÇAS (2)
intellectual developmental disorder, autosomal recessive 71autosomal recessive non-syndromic intellectual disability
HGNC:25189UniProt:Q96BT7
CLIP1CAP-Gly domain-containing linker protein 1Candidate gene tested inRestrito
FUNÇÃO

Binds to the plus end of microtubules and regulates the dynamics of the microtubule cytoskeleton. Promotes microtubule growth and microtubule bundling. Links cytoplasmic vesicles to microtubules and thereby plays an important role in intracellular vesicle trafficking. Plays a role macropinocytosis and endosome trafficking

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeletonCytoplasmic vesicle membraneCell projection, ruffle

VIAS BIOLÓGICAS (7)
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formationResolution of Sister Chromatid Cohesion
OUTRAS DOENÇAS (1)
autosomal recessive non-syndromic intellectual disability
HGNC:10461UniProt:P30622
MBOAT7Membrane-bound acylglycerophosphatidylinositol O-acyltransferase MBOAT7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Acyltransferase which catalyzes the transfer of an acyl group from an acyl-CoA to a lysophosphatidylinositol (1-acylglycerophosphatidylinositol or LPI) leading to the production of a phosphatidylinositol (1,2-diacyl-sn-glycero-3-phosphoinositol or PI) and participates in the reacylation step of the phospholipid remodeling pathway also known as the Lands cycle (PubMed:18094042, PubMed:18772128). Prefers arachidonoyl-CoA as the acyl donor, thus contributing to the regulation of free levels arachid

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Acyl chain remodelling of PI
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 57

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT57 patients have moderate to severe intellectual disability, and delayed psychomotor development with poor or absent speech. Some patients manifest seizures and autistic features.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
246.6 TPM
Glândula adrenal
146.3 TPM
Testículo
91.0 TPM
Córtex cerebral
75.1 TPM
Brain Frontal Cortex BA9
64.2 TPM
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 57autosomal recessive non-syndromic intellectual disability
HGNC:15505UniProt:Q96N66
FMN2Formin-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Actin-binding protein that is involved in actin cytoskeleton assembly and reorganization (PubMed:21730168, PubMed:22330775). Acts as an actin nucleation factor and promotes assembly of actin filaments together with SPIRE1 and SPIRE2 (PubMed:21730168, PubMed:22330775). Involved in intracellular vesicle transport along actin fibers, providing a novel link between actin cytoskeleton dynamics and intracellular transport (By similarity). Required for asymmetric spindle positioning, asymmetric oocyte

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasm, cytosolCytoplasm, perinuclear regionNucleusNucleus, nucleolusCell membraneCytoplasmic vesicle membraneCytoplasm, cell cortex

MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 47

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT47 patients show delayed development, with cognition and speech more affected than motor skills.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
16.7 TPM
Córtex cerebral
14.6 TPM
Cérebro - Hemisfério cerebelar
14.6 TPM
Cerebelo
13.9 TPM
Brain Anterior cingulate cortex BA24
13.7 TPM
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 47autosomal recessive non-syndromic intellectual disability
HGNC:14074UniProt:Q9NZ56
HNMTHistamine N-methyltransferaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Inactivates histamine by N-methylation. Plays an important role in degrading histamine and in regulating the airway response to histamine

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (2)
Histidine catabolismMetabolism of ingested SeMet, Sec, MeSec into H2Se
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 51

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
41.6 TPM
Tecido adiposo
37.3 TPM
Artéria coronária
31.8 TPM
Útero
31.6 TPM
Artéria tibial
30.4 TPM
OUTRAS DOENÇAS (3)
intellectual disability, autosomal recessive 51autosomal recessive non-syndromic intellectual disabilityinherited susceptibility to asthma
HGNC:5028UniProt:P50135
GRIA1Glutamate receptor 1Candidate gene tested inAltamente restrito
FUNÇÃO

Ionotropic glutamate receptor that functions as a ligand-gated cation channel, gated by L-glutamate and glutamatergic agonists such as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), quisqualic acid, and kainic acid (PubMed:1311100, PubMed:20805473, PubMed:21172611, PubMed:28628100, PubMed:35675825). L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation chan

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membranePostsynaptic cell membranePostsynaptic density membraneCell projection, dendriteCell projection, dendritic spineEarly endosome membraneRecycling endosome membranePresynapseSynapse

VIAS BIOLÓGICAS (1)
COPII-mediated vesicle transport
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal dominant 67

An autosomal dominant disorder characterized by global development delay and impaired intellectual development apparent from infancy or early childhood. Additional features may include behavioral abnormalities, and language and sleeping difficulties.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
76.7 TPM
Cérebro - Hemisfério cerebelar
41.8 TPM
Hipocampo
35.8 TPM
Brain Frontal Cortex BA9
34.1 TPM
Brain Anterior cingulate cortex BA24
32.6 TPM
OUTRAS DOENÇAS (4)
intellectual developmental disorder, autosomal dominant 67intellectual developmental disorder, autosomal recessive 76autosomal recessive non-syndromic intellectual disabilityautosomal dominant non-syndromic intellectual disability
HGNC:4571UniProt:P42261
TECRVery-long-chain enoyl-CoA reductaseDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Involved in both the production of very long-chain fatty acids for sphingolipid synthesis and the degradation of the sphingosine moiety in sphingolipids through the sphingosine 1-phosphate metabolic pathway (PubMed:25049234). Catalyzes the last of the four reactions of the long-chain fatty acids elongation cycle (PubMed:12482854). This endoplasmic reticulum-bound enzymatic process, allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle (PubMed:124

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Synthesis of very long-chain fatty acyl-CoAs
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 14

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
383.9 TPM
Skin Not Sun Exposed Suprapubic
293.2 TPM
Testículo
288.9 TPM
Skin Sun Exposed Lower leg
287.6 TPM
Cerebelo
285.3 TPM
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 14autosomal recessive non-syndromic intellectual disability
HGNC:4551UniProt:Q9NZ01
CEP104Centrosomal protein of 104 kDaCandidate gene tested inTolerante
FUNÇÃO

Required for ciliogenesis and for structural integrity at the ciliary tip

LOCALIZAÇÃO

Cell projection, ciliumCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centrioleCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindle pole

MECANISMO DE DOENÇA

Joubert syndrome 25

A form of Joubert syndrome, a disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis, and polydactyly. JBTS25 clinical manifestations appear to be confined to the neurologic system. JBTS25 inheritance is autosomal recessive.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (4)
Joubert syndrome 25intellectual developmental disorder, autosomal recessive 77autosomal recessive non-syndromic intellectual disabilityJoubert syndrome
HGNC:24866UniProt:O60308
TRAPPC9Trafficking protein particle complex subunit 9Candidate gene tested inTolerante
FUNÇÃO

Functions as an activator of NF-kappa-B through increased phosphorylation of the IKK complex. May function in neuronal cells differentiation. May play a role in vesicular transport from endoplasmic reticulum to Golgi

LOCALIZAÇÃO

Golgi apparatus, cis-Golgi networkEndoplasmic reticulumCytoplasm

VIAS BIOLÓGICAS (2)
COPII-mediated vesicle transportRAB GEFs exchange GTP for GDP on RABs
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 13

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Brain magnetic resonance imaging of MRT13 patients indicates the presence of mild cerebral white matter hypoplasia. Microcephaly is present in some but not all affected individuals.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
26.1 TPM
Cerebelo
21.4 TPM
Tireoide
18.6 TPM
Cérebro - Hemisfério cerebelar
18.1 TPM
Útero
18.0 TPM
OUTRAS DOENÇAS (3)
intellectual disability, autosomal recessive 13autosomal recessive non-syndromic intellectual disabilityintellectual disability-obesity-brain malformations-facial dysmorphism syndrome
HGNC:30832UniProt:Q96Q05
SLC5A1Sodium/glucose cotransporter 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Electrogenic Na(+)-coupled sugar symporter that actively transports D-glucose or D-galactose at the plasma membrane, with a Na(+) to sugar coupling ratio of 2:1. Transporter activity is driven by a transmembrane Na(+) electrochemical gradient set by the Na(+)/K(+) pump (PubMed:20980548, PubMed:34880492, PubMed:35077764, PubMed:8563765, PubMed:37217492). Has a primary role in the transport of dietary monosaccharides from enterocytes to blood. Responsible for the absorption of D-glucose or D-galac

LOCALIZAÇÃO

Apical cell membrane

VIAS BIOLÓGICAS (2)
Cellular hexose transportIntestinal hexose absorption
MECANISMO DE DOENÇA

Congenital glucose/galactose malabsorption

Intestinal monosaccharide transporter deficiency. It is an autosomal recessive disorder manifesting itself within the first weeks of life. It is characterized by severe diarrhea and dehydration which are usually fatal unless glucose and galactose are eliminated from the diet.

EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
97.9 TPM
Coração - Ventrículo esquerdo
45.4 TPM
Coração - Átrio
24.0 TPM
Glândula salivar
23.1 TPM
Skin Sun Exposed Lower leg
22.4 TPM
OUTRAS DOENÇAS (1)
glucose-galactose malabsorption
HGNC:11036UniProt:P13866
NCDNNeurochondrinCandidate gene tested inAltamente restrito
FUNÇÃO

Probably involved in signal transduction in the nervous system, via increasing cell surface localization of GRM5/mGluR5 and positively regulating its signaling (PubMed:33711248). Required for the spatial learning process. Acts as a negative regulator of Ca(2+)-calmodulin-dependent protein kinase 2 (CaMK2) phosphorylation. May play a role in modulating melanin-concentrating hormone-mediated functions via its interaction with MCHR1 that interferes with G protein-coupled signal transduction. May be

LOCALIZAÇÃO

Cytoplasm, cytosolEndosome membraneCell projection, dendritePostsynapse

MECANISMO DE DOENÇA

Neurodevelopmental disorder with infantile epileptic spasms

An autosomal dominant neurodevelopmental disorder characterized by onset of severe and frequent epileptic spasms within the first year of life. Affected individuals have global developmental delay with delayed walking and poor or absent speech. More variable features may include poor overall growth, high-arched palate, and delayed myelination on brain imaging.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Nucleus accumbens basal ganglia
839.0 TPM
Brain Caudate basal ganglia
544.0 TPM
Córtex cerebral
411.8 TPM
Brain Frontal Cortex BA9
409.5 TPM
Brain Putamen basal ganglia
349.4 TPM
OUTRAS DOENÇAS (2)
neurodevelopmental disorder with infantile epileptic spasmsautosomal recessive non-syndromic intellectual disability
HGNC:17597UniProt:Q9UBB6
ADKAdenosine kinaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Adenosine kinase that mediates the phosphorylation of the purine nucleoside adenosine at the 5' position in an ATP-dependent manner: catalyzes phosphorylation of both unmodified and modified adenosines (PubMed:21963049, PubMed:40840445, PubMed:6246102, PubMed:8577746, PubMed:9070863). Plays a key role in the detoxification of modified adenosines containing N(6)-methylated adenine (m6A) post-transcriptional modification (PubMed:40840445). Modified nucleosides are derived from the degradation of R

LOCALIZAÇÃO

Cytoplasm, cytosolNucleusCytoplasm

VIAS BIOLÓGICAS (2)
Purine salvageRibavirin ADME
MECANISMO DE DOENÇA

Hypermethioninemia due to adenosine kinase deficiency

A metabolic disorder characterized by global developmental delay, early-onset seizures, mild dysmorphic features, and characteristic biochemical anomalies, including persistent hypermethioninemia with increased levels of S-adenosylmethionine and S-adenosylhomocysteine. Homocysteine levels are typically normal.

OUTRAS DOENÇAS (1)
adenosine kinase deficiency
HGNC:257UniProt:P55263
NAA20N-alpha-acetyltransferase 20Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalytic subunit of the NatB complex which catalyzes acetylation of the N-terminal methionine residues of peptides beginning with Met-Asp, Met-Glu, Met-Asn and Met-Gln (PubMed:34230638). Proteins with cell cycle functions are overrepresented in the pool of NatB substrates. Required for maintaining the structure and function of actomyosin fibers and for proper cellular migration

LOCALIZAÇÃO

CytoplasmNucleus

MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 73

A form of intellectual disability, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT73 patients manifest global developmental delay with hypotonia and mildly delayed walking, impaired intellectual development with poor or absent speech, and mildly dysmorphic features.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
136.3 TPM
Testículo
87.2 TPM
Fibroblastos
73.4 TPM
Vagina
68.5 TPM
Tireoide
65.3 TPM
OUTRAS DOENÇAS (2)
intellectual developmental disorder, autosomal recessive 73autosomal recessive non-syndromic intellectual disability
HGNC:15908UniProt:P61599
LCTLactase/phlorizin hydrolaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Broad specificity glycosidase of the intestinal brush border membrane that hydrolyzes lactose, the main sugar in mammalian milk, to produce D-glucose and D-galactose (PubMed:12594539, PubMed:16400612, PubMed:3929764, PubMed:9762914). The mature protein is composed of two domains that catalyze the hydrolysis of beta-glucopyranosides and beta-galactopyranosides, with a preference for hydrophilic aglycones (in lactose and cellobiose) for one domain and hydrophobic aglycones (in phlorizin and glycos

LOCALIZAÇÃO

Apical cell membrane

VIAS BIOLÓGICAS (1)
Digestion of dietary carbohydrate
MECANISMO DE DOENÇA

Congenital lactase deficiency

Autosomal recessive, rare and severe gastrointestinal disorder. It is characterized by watery diarrhea in infants fed with breast milk or other lactose-containing formulas. An almost total lack of LCT activity is found in jejunal biopsy material of patients with congenital lactase deficiency. Opposite to congenital lactase deficiency, also known as lactose intolerance, is the most common enzyme deficiency worldwide. It is caused by developmental down-regulation of lactase activity during childhood or early adulthood. The decline of lactase activity is a normal physiological phenomenon; however, the majority of Northern Europeans have the ability to maintain lactase activity and digest lactose throughout life (lactase persistence). The down-regulation of lactase activity operates at the transcriptional level and it is associated with a noncoding variation in the MCM6 gene, located in the upstream vicinity of LCT.

EXPRESSÃO TECIDUAL(Baixa expressão)
Intestino delgado
1.1 TPM
Testículo
0.3 TPM
Linfócitos
0.1 TPM
Cerebelo
0.0 TPM
Cérebro - Hemisfério cerebelar
0.0 TPM
OUTRAS DOENÇAS (1)
congenital lactase deficiency
HGNC:6530UniProt:P09848
PRSS12NeurotrypsinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in neuronal plasticity and the proteolytic action may subserve structural reorganizations associated with learning and memory operations

LOCALIZAÇÃO

Secreted

MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 1

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fibroblastos
35.9 TPM
Testículo
25.6 TPM
Vagina
22.5 TPM
Cervix Ectocervix
17.8 TPM
Cervix Endocervix
12.9 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 1autosomal recessive non-syndromic intellectual disability
HGNC:9477UniProt:P56730
ASCC3Activating signal cointegrator 1 complex subunit 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

ATPase involved both in DNA repair and rescue of stalled ribosomes (PubMed:22055184, PubMed:28757607, PubMed:32099016, PubMed:32579943, PubMed:36302773). 3'-5' DNA helicase involved in repair of alkylated DNA: promotes DNA unwinding to generate single-stranded substrate needed for ALKBH3, enabling ALKBH3 to process alkylated N3-methylcytosine (3mC) within double-stranded regions (PubMed:22055184). Also involved in activation of the ribosome quality control (RQC) pathway, a pathway that degrades

LOCALIZAÇÃO

NucleusNucleus speckleCytoplasm, cytosol

VIAS BIOLÓGICAS (1)
ALKBH3 mediated reversal of alkylation damage
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 81

An autosomal recessive disorder characterized by variable features including mild to severe developmental delay, hypotonia, feeding difficulties, extreme fatigue, and neurobehavioral abnormalities.

OUTRAS DOENÇAS (1)
intellectual developmental disorder, autosomal recessive 81
HGNC:HGNC:18697UniProt:Q8N3C0
LINS1Protein Lines homolog 1Disease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 27

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
8.7 TPM
Tireoide
8.2 TPM
Baço
7.6 TPM
Útero
7.5 TPM
Cervix Endocervix
7.5 TPM
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 27autosomal recessive non-syndromic intellectual disability
HGNC:30922UniProt:Q8NG48
AGTPBP1Cytosolic carboxypeptidase 1Candidate gene tested inRestrito
FUNÇÃO

Metallocarboxypeptidase that mediates protein deglutamylation of tubulin and non-tubulin target proteins (PubMed:22170066, PubMed:24022482, PubMed:30420557). Catalyzes the removal of polyglutamate side chains present on the gamma-carboxyl group of glutamate residues within the C-terminal tail of alpha- and beta-tubulin (PubMed:22170066, PubMed:24022482, PubMed:30420557). Specifically cleaves tubulin long-side-chains, while it is not able to remove the branching point glutamate (PubMed:24022482).

LOCALIZAÇÃO

CytoplasmCytoplasm, cytosolNucleusMitochondrion

VIAS BIOLÓGICAS (1)
Carboxyterminal post-translational modifications of tubulin
MECANISMO DE DOENÇA

Neurodegeneration, childhood-onset, with cerebellar atrophy

An autosomal recessive disorder characterized by early onset of progressive neurodegeneration affecting the central and peripheral nervous systems. Clinical features include global developmental delay, impaired intellectual development, poor or absent speech, and motor abnormalities. Brain imaging shows cerebellar atrophy. Death in childhood may occur.

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
neurodegeneration, childhood-onset, with cerebellar atrophypontocerebellar hypoplasia type 1
HGNC:17258UniProt:Q9UPW5
KICS2KICSTOR subunit 2Disease-causing germline mutation(s) inModerado
FUNÇÃO

As part of the KICSTOR complex functions in the amino acid-sensing branch of the TORC1 signaling pathway. Recruits, in an amino acid-independent manner, the GATOR1 complex to the lysosomal membranes and allows its interaction with GATOR2 and the RAG GTPases. Functions upstream of the RAG GTPases and is required to negatively regulate mTORC1 signaling in absence of amino acids. In absence of the KICSTOR complex mTORC1 is constitutively localized to the lysosome and activated. The KICSTOR complex

LOCALIZAÇÃO

Lysosome membrane

VIAS BIOLÓGICAS (1)
Amino acids regulate mTORC1
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 83

An autosomal recessive disorder characterized by developmental delay, mild to moderate intellectual disability, and poor or absent speech. Additional variable features include seizures, hearing impairment, hypotonia, and non-specific facial dysmorphism.

OUTRAS DOENÇAS (1)
intellectual developmental disorder, autosomal recessive 83
HGNC:HGNC:26517UniProt:Q96MD2
EXOSC9Exosome complex component RRP45Candidate gene tested inTolerante
FUNÇÃO

Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defe

LOCALIZAÇÃO

CytoplasmNucleusNucleus, nucleolusNucleus, nucleoplasm

VIAS BIOLÓGICAS (5)
mRNA decay by 3' to 5' exoribonucleaseATF4 activates genes in response to endoplasmic reticulum stressKSRP (KHSRP) binds and destabilizes mRNAButyrate Response Factor 1 (BRF1) binds and destabilizes mRNATristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 1D

An autosomal recessive neurologic disorder with onset at birth or in infancy, and characterized by progressive axonal motor neuronopathy, severe generalized hypotonia, respiratory insufficiency, and cerebellar atrophy. Death in childhood may occur.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
43.9 TPM
Testículo
34.6 TPM
Fibroblastos
34.4 TPM
Nervo tibial
24.9 TPM
Cérebro - Hemisfério cerebelar
23.4 TPM
OUTRAS DOENÇAS (2)
pontocerebellar hypoplasia, type 1Dpontocerebellar hypoplasia type 1
HGNC:9137UniProt:Q06265
MED23Mediator of RNA polymerase II transcription subunit 23Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for transcriptional activation subsequent to the assembly of the pre-initiation complex (By similarity). Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a s

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (5)
RSV-host interactionsTranscriptional regulation of white adipocyte differentiationPPARA activates gene expressionGeneric Transcription PathwayMLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 18, with or without epilepsy

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
28.1 TPM
Cérebro - Hemisfério cerebelar
25.1 TPM
Útero
24.0 TPM
Ovário
23.3 TPM
Tireoide
21.9 TPM
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 18autosomal recessive non-syndromic intellectual disability
HGNC:2372UniProt:Q9ULK4
EZREzrinCandidate gene tested inTolerante
FUNÇÃO

Probably involved in connections of major cytoskeletal structures to the plasma membrane. In epithelial cells, required for the formation of microvilli and membrane ruffles on the apical pole. Along with PLEKHG6, required for normal macropinocytosis

LOCALIZAÇÃO

Apical cell membraneCell projectionCell projection, microvillus membraneCell projection, ruffle membraneCytoplasm, cell cortexCytoplasm, cytoskeletonCell projection, microvillus

VIAS BIOLÓGICAS (1)
Netrin-1 signaling
EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
351.1 TPM
Pulmão
303.7 TPM
Skin Sun Exposed Lower leg
299.3 TPM
Skin Not Sun Exposed Suprapubic
294.8 TPM
Linfócitos
278.7 TPM
OUTRAS DOENÇAS (1)
autosomal recessive non-syndromic intellectual disability
HGNC:12691UniProt:P15311
ZBTB11Zinc finger and BTB domain-containing protein 11Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in transcriptional regulation

LOCALIZAÇÃO

Nucleus, nucleolus

MECANISMO DE DOENÇA

Neurodevelopmental disorder with progressive movement abnormalities, cognitive decline, and brain abnormalities

An autosomal recessive disorder characterized by global developmental delay, developmental regression, variably impaired intellectual development with poor or absent speech, difficulty walking or inability to walk, and various movement abnormalities, including spasticity, hypertonia, dystonia, tremor, and myoclonus. Affected individuals usually show poor overall growth, often with microcephaly, hypotonia, limb contractures, and cataracts.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
21.7 TPM
Cérebro - Hemisfério cerebelar
21.3 TPM
Cerebelo
15.9 TPM
Fibroblastos
15.3 TPM
Útero
14.9 TPM
OUTRAS DOENÇAS (1)
intellectual developmental disorder, autosomal recessive 69
HGNC:HGNC:16740UniProt:O95625
NSUN6tRNA (cytosine(72)-C(5))-methyltransferase NSUN6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

S-adenosyl-L-methionine-dependent methyltransferase that specifically methylates the C5 position of cytosine 72 in tRNA(Thr)(TGT) and tRNA(Cys)(GCA) (PubMed:26160102, PubMed:27703015, PubMed:28531330). In vitro also methylates tRNA(Thr)(AGT) (PubMed:26160102, PubMed:27703015). Methylation requires, in the acceptor stem region, the presence of the 3'-CCA terminus, the target site C72, the discriminator base U73, and the second and third base pairs (2:71 and 3:70) in the tRNA substrates (PubMed:26

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (1)
tRNA modification in the nucleus and cytosol
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 82

An autosomal recessive disorder characterized by developmental delay, motor and speech delay, intellectual disability, and behavioral anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
37.2 TPM
Pituitária
29.5 TPM
Ovário
24.8 TPM
Fígado
24.1 TPM
Tireoide
24.1 TPM
OUTRAS DOENÇAS (1)
intellectual developmental disorder, autosomal recessive 82
HGNC:HGNC:23529UniProt:Q8TEA1
METTL5rRNA N(6)-adenosine-methyltransferase METTL5Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalytic subunit of a heterodimer with TRMT112, which specifically methylates the 6th position of adenine in position 1832 of 18S rRNA (PubMed:31328227, PubMed:32217665, PubMed:33357433, PubMed:33428944, PubMed:35033535). N6-methylation of adenine(1832) in 18S rRNA resides in the decoding center of 18S rRNA and is required for translation and embryonic stem cells (ESCs) pluripotency and differentiation (PubMed:33357433)

LOCALIZAÇÃO

NucleusPresynapsePostsynapse

MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 72

A form of intellectual disability, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT72 patients manifest moderate to severe intellectual disability, microcephaly, and dysmorphic facial features.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
65.2 TPM
Aorta
63.2 TPM
Artéria tibial
60.0 TPM
Artéria coronária
58.5 TPM
Fibroblastos
51.9 TPM
OUTRAS DOENÇAS (2)
intellectual developmental disorder, autosomal recessive 72autosomal recessive primary microcephaly
HGNC:25006UniProt:Q9NRN9
TAF13Transcription initiation factor TFIID subunit 13Disease-causing germline mutation(s) inTolerante
FUNÇÃO

The TFIID basal transcription factor complex plays a major role in the initiation of RNA polymerase II (Pol II)-dependent transcription (PubMed:33795473, PubMed:9695952). TFIID recognizes and binds promoters via its subunit TBP, a TATA-box-binding protein, and promotes assembly of the pre-initiation complex (PIC) (PubMed:33795473). The TFIID complex consists of TBP and TBP-associated factors (TAFs), including TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 and TAF13 (Pu

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (10)
Regulation of TP53 Activity through PhosphorylationRNA Polymerase II Promoter EscapeRNA Polymerase II HIV Promoter EscapeRNA Polymerase II Pre-transcription EventsHIV Transcription Initiation
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 60

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT60 patients display mild intellectual disability, delayed psychomotor development, learning difficulties, and poor overall growth with variable microcephaly.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
58.9 TPM
Brain Spinal cord cervical c-1
58.6 TPM
Brain Frontal Cortex BA9
54.1 TPM
Hipotálamo
44.8 TPM
Substância negra
43.3 TPM
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 60autosomal recessive primary microcephaly
HGNC:11546UniProt:Q15543
KDM5BLysine-specific demethylase 5BDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Histone demethylase that demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code (PubMed:24952722, PubMed:27214403, PubMed:28262558). Does not demethylate histone H3 'Lys-9' or H3 'Lys-27'. Demethylates trimethylated, dimethylated and monomethylated H3 'Lys-4'. Acts as a transcriptional corepressor for FOXG1B and PAX9. Favors the proliferation of breast cancer cells by repressing tumor suppressor genes such as BRCA1 and HOXA5 (PubMed:24952722). In contrast, may act as

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (3)
TFAP2 (AP-2) family regulates transcription of cell cycle factorsHDMs demethylate histonesChromatin modifications during the maternal to zygotic transition (MZT)
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 65

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT65 patients have moderate to severe intellectual disability, developmental delay, and facial dysmorphism. Camptodactyly is present in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
105.7 TPM
Skin Sun Exposed Lower leg
28.5 TPM
Skin Not Sun Exposed Suprapubic
27.3 TPM
Fibroblastos
24.9 TPM
Cervix Endocervix
22.2 TPM
OUTRAS DOENÇAS (3)
intellectual disability, autosomal recessive 65autosomal dominant non-syndromic intellectual disabilityautosomal recessive non-syndromic intellectual disability
HGNC:18039UniProt:Q9UGL1
RSRC1Serine/Arginine-related protein 53Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Has a role in alternative splicing and transcription regulation (PubMed:29522154). Involved in both constitutive and alternative pre-mRNA splicing. May have a role in the recognition of the 3' splice site during the second step of splicing

LOCALIZAÇÃO

NucleusNucleus speckleCytoplasm

MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 70

A form of intellectual disability, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT70 patients manifest impaired intellectual development, mild facial dysmorphism, febrile seizures, and behavioral abnormalities.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
16.5 TPM
Artéria tibial
15.5 TPM
Linfócitos
13.4 TPM
Fibroblastos
12.1 TPM
Cerebelo
10.9 TPM
OUTRAS DOENÇAS (2)
intellectual developmental disorder, autosomal recessive 70autosomal recessive non-syndromic intellectual disability
HGNC:24152UniProt:Q96IZ7
B3GALNT2UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2Candidate gene tested inTolerante
FUNÇÃO

Beta-1,3-N-acetylgalactosaminyltransferase that synthesizes a unique carbohydrate structure, GalNAc-beta-1-3GlcNAc, on N- and O-glycans. Has no galactose nor galactosaminyl transferase activity toward any acceptor substrate. Involved in alpha-dystroglycan (DAG1) glycosylation: acts coordinately with GTDC2/POMGnT2 to synthesize a GalNAc-beta3-GlcNAc-beta-terminus at the 4-position of protein O-mannose in the biosynthesis of the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3

LOCALIZAÇÃO

Golgi apparatus membraneEndoplasmic reticulum

VIAS BIOLÓGICAS (1)
DAG1 core M3 glycosylations
MECANISMO DE DOENÇA

Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A11

An autosomal recessive disorder characterized by congenital muscular dystrophy associated with cobblestone lissencephaly and other brain anomalies, eye malformations, profound intellectual disability, and death usually in the first years of life. Included diseases are the more severe Walker-Warburg syndrome and the slightly less severe muscle-eye-brain disease.

OUTRAS DOENÇAS (4)
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11muscular dystrophy-dystroglycanopathy, type Aautosomal recessive non-syndromic intellectual disabilitymuscle-eye-brain disease
HGNC:28596UniProt:Q8NCR0
SLC25A46Mitochondrial outer membrane protein SLC25A46Candidate gene tested inTolerante
FUNÇÃO

Transmembrane protein of the mitochondrial outer membrane that controls mitochondrial organization (PubMed:26168012, PubMed:27390132, PubMed:27543974). May regulate the assembly of the MICOS (mitochondrial contact site and cristae organizing system) complex which is essential to the biogenesis and dynamics of mitochondrial cristae, the inwards folds of the inner mitochondrial membrane (PubMed:27390132). Through its interaction with the EMC (endoplasmic reticulum membrane protein complex), could

LOCALIZAÇÃO

Mitochondrion outer membrane

MECANISMO DE DOENÇA

Neuropathy, hereditary motor and sensory, 6B, with optic atrophy

An autosomal recessive neurologic disorder characterized by early-onset optic atrophy, progressive visual loss, and peripheral sensorimotor neuropathy manifesting as axonal Charcot-Marie-Tooth disease, with variable age at onset and severity. Charcot-Marie-Tooth disease is a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. It is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies and primary peripheral axonal neuropathies. Peripheral axonal neuropathies are characterized by signs of axonal regeneration in the absence of obvious myelin alterations, and normal or slightly reduced nerve conduction velocities.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
35.0 TPM
Cérebro - Hemisfério cerebelar
31.7 TPM
Fibroblastos
27.1 TPM
Cerebelo
25.2 TPM
Nervo tibial
21.7 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (4)
neuropathy, hereditary motor and sensory, type 6Bpontocerebellar hypoplasia, type 1Epontocerebellar hypoplasia type 1hereditary motor and sensory neuropathy type 6
HGNC:25198UniProt:Q96AG3
WDR11WD repeat-containing protein 11Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in the Hedgehog (Hh) signaling pathway, is essential for normal ciliogenesis (PubMed:29263200). Regulates the proteolytic processing of GLI3 and cooperates with the transcription factor EMX1 in the induction of downstream Hh pathway gene expression and gonadotropin-releasing hormone production (PubMed:29263200). WDR11 complex facilitates the tethering of Adaptor protein-1 complex (AP-1)-derived vesicles. WDR11 complex acts together with TBC1D23 to facilitate the golgin-mediated capture

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium basal bodyCytoplasmNucleusCytoplasm, cytoskeleton, cilium axonemeCytoplasmic vesicleGolgi apparatus, trans-Golgi network

VIAS BIOLÓGICAS (1)
RHOH GTPase cycle
VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
30.5 TPM
Linfócitos
29.9 TPM
Nervo tibial
28.9 TPM
Útero
28.5 TPM
Cervix Ectocervix
28.3 TPM
OUTRAS DOENÇAS (5)
intellectual developmental disorder, autosomal recessive 78hypogonadotropic hypogonadism 14 with or without anosmiaKallmann syndromehypogonadotropic hypogonadism
HGNC:13831UniProt:Q9BZH6
EXOSC8Exosome complex component RRP43Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defe

LOCALIZAÇÃO

CytoplasmNucleusNucleus, nucleolus

VIAS BIOLÓGICAS (5)
mRNA decay by 3' to 5' exoribonucleaseATF4 activates genes in response to endoplasmic reticulum stressKSRP (KHSRP) binds and destabilizes mRNAButyrate Response Factor 1 (BRF1) binds and destabilizes mRNATristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 1C

A severe autosomal recessive neurodegenerative disease characterized by cerebellar and corpus callosum hypoplasia, abnormal myelination of the central nervous system, and spinal motor neuron disease. Affected individuals manifest failure to thrive, severe muscle weakness, spasticity and psychomotor retardation. Vision and hearing are impaired.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
60.2 TPM
Testículo
43.8 TPM
Ovário
40.4 TPM
Cervix Endocervix
38.1 TPM
Fallopian Tube
37.8 TPM
OUTRAS DOENÇAS (2)
pontocerebellar hypoplasia, type 1Cpontocerebellar hypoplasia type 1
HGNC:17035UniProt:Q96B26
CRBNProtein cereblonDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Substrate recognition component of a DCX (DDB1-CUL4-X-box) E3 protein ligase complex that mediates the ubiquitination and subsequent proteasomal degradation of target proteins, such as MEIS2, ILF2 or GLUL (PubMed:26990986, PubMed:33009960). Normal degradation of key regulatory proteins is required for normal limb outgrowth and expression of the fibroblast growth factor FGF8 (PubMed:20223979, PubMed:24328678, PubMed:25043012, PubMed:25108355). Maintains presynaptic glutamate release and consequen

LOCALIZAÇÃO

CytoplasmNucleusMembrane

VIAS BIOLÓGICAS (1)
Potential therapeutics for SARS
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 2

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT2 patients display mild intellectual disability with a standard IQ ranged from 50 to 70. IQ scores are lower in males than females. Developmental milestones are mildly delayed. There are no dysmorphic or autistic features.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
40.9 TPM
Testículo
39.6 TPM
Artéria tibial
39.0 TPM
Ovário
38.1 TPM
Cérebro - Hemisfério cerebelar
37.4 TPM
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 2autosomal recessive non-syndromic intellectual disability
HGNC:30185UniProt:Q96SW2
PIGCPhosphatidylinositol N-acetylglucosaminyltransferase subunit CCandidate gene tested inTolerante
FUNÇÃO

Part of the glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex that catalyzes the transfer of N-acetylglucosamine from UDP-N-acetylglucosamine to phosphatidylinositol and participates in the first step of GPI biosynthesis

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Synthesis of glycosylphosphatidylinositol (GPI)
MECANISMO DE DOENÇA

Glycosylphosphatidylinositol biosynthesis defect 16

An autosomal recessive disorder characterized by delayed psychomotor development, intellectual disability, and seizures.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
20.3 TPM
Skin Not Sun Exposed Suprapubic
19.4 TPM
Útero
17.4 TPM
Cervix Endocervix
16.4 TPM
Ovário
16.2 TPM
OUTRAS DOENÇAS (2)
glycosylphosphatidylinositol biosynthesis defect 16autosomal recessive non-syndromic intellectual disability
HGNC:8960UniProt:Q92535
GRM7Metabotropic glutamate receptor 7Candidate gene tested inRestrito
FUNÇÃO

G-protein coupled receptor activated by glutamate that regulates axon outgrowth through the MAPK-cAMP-PKA signaling pathway during neuronal development (PubMed:33500274). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors, such as adenylate cyclase that it inhibits (PubMed:9473604)

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
G alpha (i) signalling eventsClass C/3 (Metabotropic glutamate/pheromone receptors)
MECANISMO DE DOENÇA

Neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities

An autosomal recessive neurodevelopmental disorder characterized by global developmental delay, hypotonia, severe to profound intellectual disability, early-onset epilepsy, and microcephaly. Neuroimaging shows cerebral atrophy, thin corpus callosum and hypomyelination in a majority of cases. Death in childhood may occur.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Frontal Cortex BA9
4.9 TPM
Hipotálamo
3.7 TPM
Córtex cerebral
3.1 TPM
Brain Nucleus accumbens basal ganglia
2.7 TPM
Brain Anterior cingulate cortex BA24
2.6 TPM
OUTRAS DOENÇAS (3)
neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalitiesearly-infantile DEEautosomal recessive non-syndromic intellectual disability
HGNC:4599UniProt:Q14831
CRADDDeath domain-containing protein CRADDDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Adapter protein that associates with PIDD1 and the caspase CASP2 to form the PIDDosome, a complex that activates CASP2 and triggers apoptosis (PubMed:15073321, PubMed:16652156, PubMed:17159900, PubMed:17289572, PubMed:9044836). Also recruits CASP2 to the TNFR-1 signaling complex through its interaction with RIPK1 and TRADD and may play a role in the tumor necrosis factor-mediated signaling pathway (PubMed:8985253)

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
TP53 Regulates Transcription of Caspase Activators and Caspases
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 34, with variant lissencephaly

A disorder characterized by mild to moderate intellectual disability, megalencephaly or enlarged head circumference, and a mild variant of lissencephaly with anterior-predominant pachygyria with shallow and unusually wide sulci and mildly thickened cortex. Some patients may have seizures.

OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 34autosomal recessive non-syndromic intellectual disability
HGNC:2340UniProt:P78560
MED25Mediator of RNA polymerase II transcription subunit 9Candidate gene tested inTolerante
FUNÇÃO

Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcriptio

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (4)
RSV-host interactionsTranscriptional regulation of white adipocyte differentiationPPARA activates gene expressionGeneric Transcription Pathway
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
183.1 TPM
Glândula adrenal
101.3 TPM
Ovário
88.7 TPM
Tireoide
85.0 TPM
Pituitária
76.9 TPM
OUTRAS DOENÇAS (2)
congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndromeautosomal recessive non-syndromic intellectual disability
HGNC:28845UniProt:Q9NWA0
METTL23Histone-arginine methyltransferase METTL23Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Histone methyltransferase that dimethylates histone H3 at 'Arg-17', forming asymmetric dimethylarginine (H3R17me2a), leading to activate transcription via chromatin remodeling (By similarity). Maternal factor involved in epigenetic chromatin reprogramming of the paternal genome in the zygote: mediates H3R17me2a, promoting histone H3.3 incorporation in the male pronucleus, leading to TET3 recruitment and subsequent DNA demethylation (By similarity)

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (2)
Replacement of protamines by nucleosomes in the male pronucleusChromatin modifications during the maternal to zygotic transition (MZT)
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 44

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT44 manifestations include mild to severe cognitive impairment, delayed psychomotor development, seizures in some patients, and dysmorphic features.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
64.5 TPM
Tireoide
44.0 TPM
Baço
43.3 TPM
Cervix Endocervix
37.0 TPM
Pituitária
33.3 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 44autosomal recessive non-syndromic intellectual disability
HGNC:26988UniProt:Q86XA0
IMPA1Inositol monophosphatase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Phosphatase involved in the dephosphorylation of myo-inositol monophosphates to generate myo-inositol (PubMed:17068342, PubMed:8718889, PubMed:9462881). Is also able to dephosphorylate scyllo-inositol-phosphate, myo-inositol 1,4-diphosphate, scyllo-inositol-1,3-diphosphate and scyllo-inositol-1,4-diphosphate (PubMed:17068342). Also dephosphorylates in vitro other sugar-phosphates including D-galactose-1-phosphate, glucose-1-phosphate, glucose-6-phosphate, fructose-1-phosphate, beta-glycerophosph

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (1)
Synthesis of IP2, IP, and Ins in the cytosol
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 59

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
33.7 TPM
Testículo
33.6 TPM
Tireoide
31.9 TPM
Brain Frontal Cortex BA9
20.1 TPM
Intestino delgado
19.9 TPM
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 59autosomal recessive non-syndromic intellectual disability
HGNC:6050UniProt:P29218
EIF3FEukaryotic translation initiation factor 3 subunit FDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. T

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (6)
Translation initiation complex formationRibosomal scanning and start codon recognitionGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expressionFormation of the ternary complex, and subsequently, the 43S complex
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 67

A form of intellectual disability, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Some MRT67 patients manifest seizures and sensorineural hearing loss.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
113.9 TPM
Fibroblastos
102.2 TPM
Cervix Ectocervix
97.1 TPM
Útero
86.2 TPM
Skin Sun Exposed Lower leg
83.3 TPM
OUTRAS DOENÇAS (1)
intellectual developmental disorder, autosomal recessive 67
HGNC:HGNC:3275UniProt:O00303
DCPSm7GpppX diphosphataseCandidate gene tested inTolerante
FUNÇÃO

Decapping scavenger enzyme that catalyzes the cleavage of a residual cap structure following the degradation of mRNAs by the 3'->5' exosome-mediated mRNA decay pathway. Hydrolyzes cap analog structures like 7-methylguanosine nucleoside triphosphate (m7GpppG) with up to 10 nucleotide substrates (small capped oligoribonucleotides) and specifically releases 5'-phosphorylated RNA fragments and 7-methylguanosine monophosphate (m7GMP). Cleaves cap analog structures like tri-methyl guanosine nucleoside

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
mRNA decay by 3' to 5' exoribonuclease
MECANISMO DE DOENÇA

Al-Raqad syndrome

A syndrome characterized by delayed psychomotor development, moderate to severe intellectual disability, poor or absent speech, microcephaly, congenital hypotonia, and severe growth delay.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
83.9 TPM
Fígado
43.7 TPM
Baço
30.2 TPM
Fibroblastos
29.4 TPM
Cervix Endocervix
28.8 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
Al-Raqad syndromeautosomal recessive non-syndromic intellectual disability
HGNC:29812UniProt:Q96C86
APC2Apolipoprotein C-IIDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of chylomicrons, very low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL) in plasma. Plays an important role in lipoprotein metabolism as an activator of lipoprotein lipase. Both proapolipoprotein C-II and apolipoprotein C-II can activate lipoprotein lipase. In normolipidemic individuals, it is mainly distributed in the HDL, whereas in hypertriglyceridemic individuals, predominantly found in the VLDL and LDL

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (10)
Inactivation of APC/C via direct inhibition of the APC/C complexCdc20:Phospho-APC/C mediated degradation of Cyclin AAPC-Cdc20 mediated degradation of Nek2AAPC/C:Cdc20 mediated degradation of mitotic proteinsAPC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
MECANISMO DE DOENÇA

Hyperlipoproteinemia 1B

Autosomal recessive trait characterized by hypertriglyceridemia, xanthomas, and increased risk of pancreatitis and early atherosclerosis.

OUTRAS DOENÇAS (3)
intellectual developmental disorder, autosomal recessive 74cortical dysplasia, complex, with other brain malformations 10Sotos syndrome
HGNC:24036UniProt:P02655
FERRY3Ferry endosomal RAB5 effector complex subunit 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the FERRY complex (Five-subunit Endosomal Rab5 and RNA/ribosome intermediary) (PubMed:37267905). The FERRY complex directly interacts with mRNAs and RAB5A, and functions as a RAB5A effector involved in the localization and the distribution of specific mRNAs most likely by mediating their endosomal transport. The complex recruits mRNAs and ribosomes to early endosomes through direct mRNA-interaction (PubMed:37267905). Plays a role in mast cell degranulation

LOCALIZAÇÃO

CytoplasmEarly endosome

MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 66

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT66 patients have intellectual disability, delayed speech development, neuropsychiatric symptoms, and relatively normal life span.

OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 66autosomal recessive non-syndromic intellectual disability
HGNC:1184UniProt:Q9NQ89
PGAP1GPI inositol-deacylaseCandidate gene tested inTolerante
FUNÇÃO

GPI inositol-deacylase that catalyzes the remove of the acyl chain linked to the 2-OH position of inositol ring from the GPI-anchored protein (GPI-AP) in the endoplasmic reticulum (PubMed:24784135, PubMed:38167496). Initiates the post-attachment remodeling phase of GPI-AP biogenesis and participates in endoplasmic reticulum (ER)-to-Golgi transport of GPI-anchored protein (PubMed:24784135, PubMed:38167496)

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Attachment of GPI anchor to uPAR
MECANISMO DE DOENÇA

Neurodevelopmental disorder with dysmorphic features, spasticity, and brain abnormalities

An autosomal recessive disorder characterized by severely delayed global development, with hypotonia, impaired intellectual development, and poor or absent speech. Most patients have spasticity with limb hypertonia and brisk tendon reflexes. Additional features include non-specific dysmorphic facial features, structural brain abnormalities, and cortical visual impairment.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
15.2 TPM
Cérebro - Hemisfério cerebelar
12.8 TPM
Cerebelo
12.7 TPM
Skin Not Sun Exposed Suprapubic
12.1 TPM
Skin Sun Exposed Lower leg
10.1 TPM
OUTRAS DOENÇAS (3)
intellectual disability, autosomal recessive 42autosomal recessive spastic paraplegia type 67autosomal recessive non-syndromic intellectual disability
HGNC:25712UniProt:Q75T13
IQSEC1IQ motif and SEC7 domain-containing protein 1Candidate gene tested inAltamente restrito
FUNÇÃO

Guanine nucleotide exchange factor for ARF1 and ARF6 (PubMed:11226253, PubMed:24058294). Guanine nucleotide exchange factor activity is enhanced by lipid binding (PubMed:24058294). Accelerates GTP binding by ARFs of all three classes. Guanine nucleotide exchange protein for ARF6, mediating internalization of beta-1 integrin (PubMed:16461286). Involved in neuronal development (Probable). In neurons, plays a role in the control of vesicle formation by endocytoc cargo. Upon long term depression, in

LOCALIZAÇÃO

CytoplasmNucleusPostsynaptic densityCytoplasmic vesicle, secretory vesicle, synaptic vesicle

MECANISMO DE DOENÇA

Intellectual developmental disorder with short stature and behavioral abnormalities

An autosomal recessive disorder with onset in infancy and characterized by intellectual disability, developmental delay, short stature, aphasia, and hypotonia. Additional features include seizures and behavioral abnormalities, such as inattention, hyperactivity and aggression.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Frontal Cortex BA9
105.8 TPM
Córtex cerebral
102.0 TPM
Cerebelo
87.0 TPM
Brain Anterior cingulate cortex BA24
79.7 TPM
Cérebro - Hemisfério cerebelar
78.6 TPM
OUTRAS DOENÇAS (2)
intellectual developmental disorder with short stature and behavioral abnormalitiesautosomal recessive non-syndromic intellectual disability
HGNC:29112UniProt:Q6DN90
GRIK2Glutamate receptor ionotropic, kainate 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Ionotropic glutamate receptor that functions as a cation-permeable ligand-gated ion channel, gated by L-glutamate and the glutamatergic agonist kainic acid (PubMed:7536611, PubMed:8730589, PubMed:14511640). L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system (By similarity). Binding of the excitatory neurotransmitter L-glutamate induces a conformational change leading to the opening of the cation channel, converting the chemical signal to an electric

LOCALIZAÇÃO

Cell membranePostsynaptic cell membrane

VIAS BIOLÓGICAS (1)
Activation of Ca-permeable Kainate Receptor
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 6

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT6 patients display mild to severe intellectual disability and psychomotor development delay in early childhood. Patients do not have neurologic problems, congenital malformations, or facial dysmorphism. Body height, weight, and head circumference are normal.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
95.5 TPM
Cerebelo
83.8 TPM
Hipotálamo
16.0 TPM
Brain Frontal Cortex BA9
14.5 TPM
Córtex cerebral
13.7 TPM
OUTRAS DOENÇAS (4)
intellectual disability, autosomal recessive 6neurodevelopmental disorder with impaired language and ataxia and with or without seizurescomplex neurodevelopmental disorderautosomal recessive non-syndromic intellectual disability
HGNC:4580UniProt:Q13002
RUSC2AP-4 complex accessory subunit RUSC2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Associates with the adapter-like complex 4 (AP-4) and may therefore play a role in vesicular trafficking of proteins at the trans-Golgi network

LOCALIZAÇÃO

Cytoplasm, cytosolCell membrane

MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 61

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT61 patients manifest delayed psychomotor development, moderate to severe intellectual disability, and variable dysmorphic facial features. Refractory seizures and brain abnormalities are present in severely affected patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
112.9 TPM
Artéria tibial
112.5 TPM
Cerebelo
108.8 TPM
Cérebro - Hemisfério cerebelar
99.5 TPM
Córtex cerebral
78.6 TPM
OUTRAS DOENÇAS (1)
intellectual disability, autosomal recessive 61
HGNC:HGNC:23625UniProt:Q8N2Y8
SLC17A5SialinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Multifunctional anion transporter that operates via two distinct transport mechanisms, namely proton-coupled anion cotransport and membrane potential-dependent anion transport (PubMed:15510212, PubMed:21781115, PubMed:22778404, PubMed:23889254). Electroneutral proton-coupled acidic monosaccharide symporter, with a sugar to proton stoichiometry of 1:1. Exports glucuronic acid and free sialic acid derived from sialoglycoconjugate degradation out of lysosomes, driven by outwardly directed lysosomal

LOCALIZAÇÃO

Basolateral cell membraneCytoplasmic vesicle, secretory vesicle, synaptic vesicle membraneLysosome membrane

VIAS BIOLÓGICAS (3)
Organic anion transport by SLC5/17/25 transportersSialic acid metabolismHyaluronan degradation
MECANISMO DE DOENÇA

Salla disease

Sialic acid storage disease (SASD). SASDs are autosomal recessive neurodegenerative disorders characterized by hypotonia, cerebellar ataxia and intellectual disability. They are caused by a defect in the metabolism of sialic acid which results in increased urinary excretion of unconjugated sialic acid, specifically N-acetylneuraminic acid. Enlarged lysosomes are seen on electron microscopic studies. Clinical symptoms of SD present usually at age less than 1 year and progression is slow.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
53.3 TPM
Fibroblastos
40.9 TPM
Glândula salivar
31.2 TPM
Aorta
27.6 TPM
Artéria coronária
23.4 TPM
OUTRAS DOENÇAS (3)
Salla diseasefree sialic acid storage disease, infantile formintermediate severe Salla disease
HGNC:10933UniProt:Q9NRA2
TREHTrehalaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Intestinal trehalase is probably involved in the hydrolysis of ingested trehalose

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
Digestion of dietary carbohydrate
MECANISMO DE DOENÇA

Trehalase deficiency

An autosomal recessive condition characterized by the inability to digest trehalose, a disaccharide found in mushrooms, products containing baker's yeast, and dried food. Individuals with trehalase deficiency suffer from abdominal pain, increased rectal flatulence, and diarrhea due to osmotic water flow into the colon.

EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
11.2 TPM
Testículo
5.5 TPM
Rim - Córtex
4.8 TPM
Rim - Medula
2.1 TPM
Esôfago - Mucosa
1.9 TPM
OUTRAS DOENÇAS (1)
diarrhea-vomiting due to trehalase deficiency
HGNC:12266UniProt:O43280
SLC16A12Monocarboxylate transporter 12Candidate gene tested inModerado
FUNÇÃO

Functions as a transporter for creatine and as well for its precursor guanidinoacetate. Transport of creatine and GAA is independent of resting membrane potential and extracellular Na(+), Cl(-), or pH. Contributes to the process of creatine biosynthesis and distribution

LOCALIZAÇÃO

Cell membraneBasolateral cell membrane

MECANISMO DE DOENÇA

Cataract 47

A form of cataract, an opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT47 is characterized by the association of cataract with microcornea and renal glucosuria. Microcornea is defined by a corneal diameter inferior to 10 mm in both meridians in an otherwise normal eye. Renal glucosuria is defined by elevated glucose level in the urine without hyperglycemia and without evidence of morphological renal anomalies.

EXPRESSÃO TECIDUAL(Tecido-específico)
Nervo tibial
22.2 TPM
Pâncreas
17.0 TPM
Rim - Medula
11.9 TPM
Rim - Córtex
10.1 TPM
Tireoide
7.5 TPM
OUTRAS DOENÇAS (1)
juvenile cataract-microcornea-renal glucosuria syndrome
HGNC:23094UniProt:Q6ZSM3
UBE4AUbiquitin conjugation factor E4 ACandidate gene tested inRestrito
FUNÇÃO

Ubiquitin-protein ligase that probably functions as an E3 ligase in conjunction with specific E1 and E2 ligases. May also function as an E4 ligase mediating the assembly of polyubiquitin chains on substrates ubiquitinated by another E3 ubiquitin ligase. Mediates 'Lys-48'-linked polyubiquitination of substrates

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (1)
Antigen processing: Ubiquitination & Proteasome degradation
MECANISMO DE DOENÇA

Neurodevelopmental disorder with hypotonia and gross motor and speech delay

An autosomal recessive disorder characterized by severe global developmental delay apparent from infancy, axial hypotonia, limited or absent ability to walk, impaired intellectual development, and poor or absent speech. Additional features may include seizures, behavioral problems, distal skeletal anomalies, and facial dysmorphism.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
36.0 TPM
Fibroblastos
34.6 TPM
Cérebro - Hemisfério cerebelar
33.6 TPM
Linfócitos
33.6 TPM
Nervo tibial
27.9 TPM
OUTRAS DOENÇAS (2)
neurodevelopmental disorder with hypotonia and gross motor and speech delayautosomal recessive non-syndromic intellectual disability
HGNC:12499UniProt:Q14139
SLC5A2Sodium/glucose cotransporter 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Electrogenic Na(+)-coupled sugar symporter that actively transports D-glucose at the plasma membrane, with a Na(+) to sugar coupling ratio of 1:1 (PubMed:20980548, PubMed:28592437, PubMed:34880493, PubMed:37217492, PubMed:38057552). Transporter activity is driven by a transmembrane Na(+) electrochemical gradient set by the Na(+)/K(+) pump (PubMed:20980548, PubMed:28592437, PubMed:34880493). Unlike SLC5A1/SGLT1, requires the auxiliary protein PDZK1IP1/MAP17 for full transporter activity (PubMed:3

LOCALIZAÇÃO

Apical cell membrane

VIAS BIOLÓGICAS (1)
Cellular hexose transport
MECANISMO DE DOENÇA

Renal glucosuria

A disorder characterized by persistent isolated glucosuria, normal fasting serum glucose concentration, decreased renal tubular resorption of glucose from the urine, and absence of any other signs of tubular dysfunction.

EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Córtex
36.0 TPM
Rim - Medula
25.3 TPM
Testículo
16.0 TPM
Cérebro - Hemisfério cerebelar
1.1 TPM
Cerebelo
1.0 TPM
OUTRAS DOENÇAS (1)
familial renal glucosuria
HGNC:11037UniProt:P31639
TRMT1tRNA (guanine(26)-N(2))-dimethyltransferaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Dimethylates a single guanine residue at position 26 of most nuclear- and mitochondrial-encoded tRNAs using S-adenosyl-L-methionine as donor of the methyl groups (PubMed:10982862, PubMed:28784718, PubMed:37204604, PubMed:39786990). tRNA guanine(26)-dimethylation is required for redox homeostasis and ensure proper cellular proliferation and oxidative stress survival (PubMed:28784718)

LOCALIZAÇÃO

MitochondrionNucleusCytoplasm

VIAS BIOLÓGICAS (1)
tRNA modification in the nucleus and cytosol
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 68

A form of intellectual disability, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
67.3 TPM
Baço
64.6 TPM
Útero
63.8 TPM
Ovário
63.3 TPM
Cervix Endocervix
62.1 TPM
OUTRAS DOENÇAS (2)
intellectual developmental disorder, autosomal recessive 68complex neurodevelopmental disorder
HGNC:25980UniProt:Q9NXH9
LINGO1Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Functional component of the Nogo receptor signaling complex (RTN4R/NGFR) in RhoA activation responsible for some inhibition of axonal regeneration by myelin-associated factors (PubMed:14966521, PubMed:15694321). Is also an important negative regulator of oligodentrocyte differentiation and axonal myelination (PubMed:15895088). Acts in conjunction with RTN4 and RTN4R in regulating neuronal precursor cell motility during cortical development (By similarity)

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
Axonal growth inhibition (RHOA activation)
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 64

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT64 patients have moderate to severe intellectual disability, delayed motor development, aggressive behavior, and slurred or absent speech.

EXPRESSÃO TECIDUAL(Ubíquo)
Córtex cerebral
92.5 TPM
Brain Frontal Cortex BA9
91.5 TPM
Brain Anterior cingulate cortex BA24
55.8 TPM
Hipocampo
38.6 TPM
Cérebro - Amígdala
35.0 TPM
OUTRAS DOENÇAS (1)
intellectual disability, autosomal recessive 64
HGNC:HGNC:21205UniProt:Q96FE5
MAN1B1Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in glycoprotein quality control targeting of misfolded glycoproteins for degradation. It primarily trims a single alpha-1,2-linked mannose residue from Man(9)GlcNAc(2) to produce Man(8)GlcNAc(2), but at high enzyme concentrations, as found in the ER quality control compartment (ERQC), it further trims the carbohydrates to Man(5-6)GlcNAc(2)

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (2)
Maturation of spike proteinER Quality Control Compartment (ERQC)
MECANISMO DE DOENÇA

Rafiq syndrome

An autosomal recessive disorder characterized by variably impaired intellectual and motor development, a characteristic facial dysmorphism, truncal obesity, and hypotonia. The facial dysmorphism comprises prominent eyebrows with lateral thinning, downward-slanting palpebral fissures, bulbous tip of the nose, large ears, and a thin upper lip. Behavioral problems, including overeating, verbal and physical aggression, have been reported in some cases. Serum transferrin isoelectric focusing shows a type 2 pattern.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
63.3 TPM
Nervo tibial
51.8 TPM
Pituitária
49.8 TPM
Testículo
49.4 TPM
Cérebro - Hemisfério cerebelar
47.3 TPM
OUTRAS DOENÇAS (3)
Rafiq syndromeMAN1B1-congenital disorder of glycosylationautosomal recessive non-syndromic intellectual disability
HGNC:6823UniProt:Q9UKM7
WASHC4WASH complex subunit 4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts as a component of the WASH core complex that functions as a nucleation-promoting factor (NPF) at the surface of endosomes, where it recruits and activates the Arp2/3 complex to induce actin polymerization, playing a key role in the fission of tubules that serve as transport intermediates during endosome sorting

LOCALIZAÇÃO

Early endosome

MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 43

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
44.9 TPM
Fibroblastos
43.7 TPM
Nervo tibial
39.5 TPM
Tecido adiposo
35.3 TPM
Cervix Ectocervix
35.2 TPM
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 43autosomal recessive non-syndromic intellectual disability
HGNC:29174UniProt:Q2M389
TPRNucleoprotein TPRCandidate gene tested inAltamente restrito
FUNÇÃO

Component of the nuclear pore complex (NPC), a complex required for the trafficking across the nuclear envelope. Functions as a scaffolding element in the nuclear phase of the NPC essential for normal nucleocytoplasmic transport of proteins and mRNAs, plays a role in the establishment of nuclear-peripheral chromatin compartmentalization in interphase, and in the mitotic spindle checkpoint signaling during mitosis. Involved in the quality control and retention of unspliced mRNAs in the nucleus; i

LOCALIZAÇÃO

NucleusNucleus membraneNucleus envelopeNucleus, nuclear pore complexCytoplasmCytoplasm, cytoskeleton, spindleChromosome, centromere, kinetochore

VIAS BIOLÓGICAS (10)
snRNP AssemblyHCMV Early EventsHCMV Late EventsNEP/NS2 Interacts with the Cellular Export MachineryTransport of Ribonucleoproteins into the Host Nucleus
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
75.9 TPM
Linfócitos
72.8 TPM
Fibroblastos
64.6 TPM
Tireoide
48.7 TPM
Ovário
48.7 TPM
OUTRAS DOENÇAS (3)
intellectual developmental disorder, autosomal recessive 79autosomal recessive non-syndromic intellectual disabilitydifferentiated thyroid carcinoma
HGNC:12017UniProt:P12270
NDST1Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Essential bifunctional enzyme that catalyzes both the N-deacetylation and the N-sulfation of glucosamine (GlcNAc) of the glycosaminoglycan in heparan sulfate (PubMed:35137078, PubMed:9230113, PubMed:9744796). Modifies the GlcNAc-GlcA disaccharide repeating sugar backbone to make N-sulfated heparosan, a prerequisite substrate for later modifications in heparin biosynthesis (PubMed:9230113). Plays a role in determining the extent and pattern of sulfation of heparan sulfate. Participates in biosynt

LOCALIZAÇÃO

Golgi apparatus, trans-Golgi network membraneGolgi apparatus, cis-Golgi network membrane

VIAS BIOLÓGICAS (1)
HS-GAG biosynthesis
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 46

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT46 manifestations include delayed psychomotor development apparent from infancy or early childhood, delayed or absent expressive speech, hypotonia, and therapy-responsive seizures in some patients. Behavioral abnormalities are variable and include aggression, self-injurious behavior, and sleep disturbances.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
85.9 TPM
Baço
62.8 TPM
Nervo tibial
53.1 TPM
Esôfago - Mucosa
52.1 TPM
Brain Spinal cord cervical c-1
51.7 TPM
OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 46autosomal recessive non-syndromic intellectual disability
HGNC:7680UniProt:P52848
SLC2A1Solute carrier family 2, facilitated glucose transporter member 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Facilitative glucose transporter, which is responsible for constitutive or basal glucose uptake (PubMed:10227690, PubMed:10954735, PubMed:18245775, PubMed:19449892, PubMed:25982116, PubMed:27078104, PubMed:32860739). Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses (PubMed:18245775, PubMed:19449892). Most important energy carrier of the brain: present at the blood-brain barrier and assures the energy-independent, facilitative trans

LOCALIZAÇÃO

Cell membraneMelanosomePhotoreceptor inner segment

VIAS BIOLÓGICAS (3)
Vitamin C (ascorbate) metabolismCellular hexose transportRegulation of insulin secretion
MECANISMO DE DOENÇA

GLUT1 deficiency syndrome 1

A neurologic disorder showing wide phenotypic variability. The most severe 'classic' phenotype comprises infantile-onset epileptic encephalopathy associated with delayed development, acquired microcephaly, motor incoordination, and spasticity. Onset of seizures, usually characterized by apneic episodes, staring spells, and episodic eye movements, occurs within the first 4 months of life. Other paroxysmal findings include intermittent ataxia, confusion, lethargy, sleep disturbance, and headache. Varying degrees of cognitive impairment can occur, ranging from learning disabilities to severe intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
703.8 TPM
Skin Not Sun Exposed Suprapubic
272.6 TPM
Skin Sun Exposed Lower leg
265.8 TPM
Vagina
176.1 TPM
Esôfago - Mucosa
154.8 TPM
OUTRAS DOENÇAS (8)
childhood onset GLUT1 deficiency syndrome 2hereditary cryohydrocytosis with reduced stomatindystonia 9encephalopathy due to GLUT1 deficiency
HGNC:11005UniProt:P11166
CHKACholine kinase alphaCandidate gene tested inTolerante
FUNÇÃO

Plays a key role in phospholipid biosynthesis by catalyzing the phosphorylation of free choline to phosphocholine, the first step in phosphatidylcholine biosynthesis (PubMed:17007874, PubMed:19915674, PubMed:23416529, PubMed:34077757). Also phosphorylates ethanolamine, thereby contributing to phosphatidylethanolamine biosynthesis (PubMed:17007874, PubMed:19915674). Has higher activity with choline (PubMed:17007874, PubMed:19915674). May contribute to tumor cell growth (PubMed:19915674) This isof

LOCALIZAÇÃO

Cytoplasm, cytosolLipid droplet

VIAS BIOLÓGICAS (2)
Synthesis of PCSynthesis of PE
MECANISMO DE DOENÇA

Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures

An autosomal recessive neurodevelopmental disorder characterized by severe global developmental delay, impaired intellectual development, microcephaly, early-onset seizures, and movement abnormalities.

OUTRAS DOENÇAS (2)
neurodevelopmental disorder with microcephaly, movement abnormalities, and seizuresautosomal recessive non-syndromic intellectual disability
HGNC:1937UniProt:P35790
CC2D1ACoiled-coil and C2 domain-containing protein 1ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Transcription factor that binds specifically to the DRE (dual repressor element) and represses HTR1A gene transcription in neuronal cells. The combination of calcium and ATP specifically inactivates the binding with FRE. May play a role in the altered regulation of HTR1A associated with anxiety and major depression. Mediates HDAC-independent repression of HTR1A promoter in neuronal cell. Performs essential function in controlling functional maturation of synapses (By similarity). Plays distinct

LOCALIZAÇÃO

CytoplasmNucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosome

MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal recessive 3

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.

OUTRAS DOENÇAS (2)
intellectual disability, autosomal recessive 3autosomal recessive non-syndromic intellectual disability
HGNC:30237UniProt:Q6P1N0

Variantes genéticas (ClinVar)

234 variantes patogênicas registradas no ClinVar.

🧬 PIDD1: GRCh38/hg38 11p15.5-15.4(chr11:198510-3400939)x3 ()
🧬 PIDD1: NM_145886.4(PIDD1):c.1176+5G>A ()
🧬 PIDD1: NM_145886.4(PIDD1):c.1177-7C>A ()
🧬 PIDD1: NM_145886.4(PIDD1):c.1630+9C>T ()
🧬 PIDD1: NM_145886.4(PIDD1):c.2041+17A>G ()
Ver todas no ClinVar

Vias biológicas (Reactome)

152 vias biológicas associadas aos genes desta condição.

TP53 Regulates Transcription of Caspase Activators and Caspases TP53 Regulates Transcription of Cell Death Genes ATF4 activates genes in response to endoplasmic reticulum stress mRNA decay by 3' to 5' exoribonuclease Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA KSRP (KHSRP) binds and destabilizes mRNA Major pathway of rRNA processing in the nucleolus and cytosol Nuclear RNA decay Nuclear Envelope Breakdown Initiation of Nuclear Envelope (NE) Reformation Digestion of dietary carbohydrate Intestinal saccharidase deficiencies Selenoamino acid metabolism Cytosolic tRNA aminoacylation Transcriptional and post-translational regulation of MITF-M expression and activity Pre-NOTCH Processing in Golgi Keratan sulfate biosynthesis Defective ST3GAL3 causes MCT12 and EIEE15 Sialic acid metabolism Lewis blood group biosynthesis Maturation of protein 3a Maturation of spike protein Maturation of protein 3a Termination of O-glycan biosynthesis Glycosphingolipid biosynthesis tRNA modification in the nucleus and cytosol mRNA decay by 5' to 3' exoribonuclease Asparagine N-linked glycosylation Miscellaneous transport and binding events Maturation of DENV proteins PD-L1(CD274) glycosylation and translocation to plasma membrane Oxidative Stress Induced Senescence Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion RHO GTPases activate IQGAPs RHO GTPases Activate Formins Mitotic Prometaphase EML4 and NUDC in mitotic spindle formation Signaling by LTK in cancer Acyl chain remodelling of PI Metabolism of ingested SeMet, Sec, MeSec into H2Se Histidine catabolism COPII-mediated vesicle transport Activation of AMPA receptors Trafficking of AMPA receptors Trafficking of GluR2-containing AMPA receptors Unblocking of NMDA receptors, glutamate binding and activation Cargo concentration in the ER Synaptic adhesion-like molecules Long-term potentiation Synthesis of very long-chain fatty acyl-CoAs RAB GEFs exchange GTP for GDP on RABs Cellular hexose transport Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM) Intestinal hexose absorption Purine salvage Ribavirin ADME ALKBH3 mediated reversal of alkylation damage ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA Carboxyterminal post-translational modifications of tubulin Amino acids regulate mTORC1 PPARA activates gene expression Generic Transcription Pathway Transcriptional regulation of white adipocyte differentiation RSV-host interactions MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis Netrin-1 signaling Recycling pathway of L1 Sensory processing of sound by inner hair cells of the cochlea Sensory processing of sound by outer hair cells of the cochlea HIV Transcription Initiation RNA Polymerase II HIV Promoter Escape Transcription of the HIV genome RNA Polymerase II Pre-transcription Events Regulation of TP53 Activity through Phosphorylation RNA polymerase II transcribes snRNA genes RNA Polymerase II Promoter Escape RNA Polymerase II Transcription Pre-Initiation And Promoter Opening RNA Polymerase II Transcription Initiation RNA Polymerase II Transcription Initiation And Promoter Clearance HDMs demethylate histones TFAP2 (AP-2) family regulates transcription of cell cycle factors Chromatin modifications during the maternal to zygotic transition (MZT) DAG1 core M3 glycosylations RHOH GTPase cycle Potential therapeutics for SARS Synthesis of glycosylphosphatidylinositol (GPI) G alpha (i) signalling events Class C/3 (Metabotropic glutamate/pheromone receptors) Replacement of protamines by nucleosomes in the male pronucleus Synthesis of IP2, IP, and Ins in the cytosol L13a-mediated translational silencing of Ceruloplasmin expression Translation initiation complex formation Formation of a pool of free 40S subunits Formation of the ternary complex, and subsequently, the 43S complex Ribosomal scanning and start codon recognition GTP hydrolysis and joining of the 60S ribosomal subunit Chylomicron assembly Assembly of active LPL and LIPC lipase complexes Chylomicron remodeling HDL remodeling NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux Retinoid metabolism and transport Attachment of GPI anchor to uPAR Recruitment of AP-2 complex and clathrin Activation of Na-permeable kainate receptors Activation of Ca-permeable Kainate Receptor Hyaluronan degradation Organic anion transport by SLC5/17/25 transporters Defective SLC17A5 causes Salla disease (SD) and ISSD Antigen processing: Ubiquitination & Proteasome degradation Defective SLC5A2 causes renal glucosuria (GLYS1) Axonal growth inhibition (RHOA activation) Defective MAN1B1 causes MRT15 ER Quality Control Compartment (ERQC) ISG15 antiviral mechanism Transport of the SLBP independent Mature mRNA Transport of the SLBP Dependant Mature mRNA Transport of Mature mRNA Derived from an Intronless Transcript Transport of Mature mRNA derived from an Intron-Containing Transcript Rev-mediated nuclear export of HIV RNA Transport of Ribonucleoproteins into the Host Nucleus NS1 Mediated Effects on Host Pathways Viral Messenger RNA Synthesis NEP/NS2 Interacts with the Cellular Export Machinery Regulation of Glucokinase by Glucokinase Regulatory Protein Nuclear import of Rev protein Vpr-mediated nuclear import of PICs snRNP Assembly SUMOylation of DNA damage response and repair proteins SUMOylation of ubiquitinylation proteins Nuclear Pore Complex (NPC) Disassembly Regulation of HSF1-mediated heat shock response SUMOylation of SUMOylation proteins SUMOylation of chromatin organization proteins SUMOylation of RNA binding proteins SUMOylation of DNA replication proteins Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) tRNA processing in the nucleus HCMV Early Events HCMV Late Events SARS-CoV-2 activates/modulates innate and adaptive immune responses Signaling by ALK fusions and activated point mutants HS-GAG biosynthesis Vitamin C (ascorbate) metabolism Regulation of insulin secretion Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) Lactose synthesis Synthesis of PC Synthesis of PE

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Alteração da absorção e transporte de carboidratos

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Novel anti-rheumatic potential of Eucalrobusone C: inhibition of rheumatoid arthritis fibroblast-like synoviocytes and metabolic reprogramming.

Artificial cells, nanomedicine, and biotechnology2026 Dec

Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by synovial hyperplasia, inflammatory cell infiltration, and joint destruction. This study investigates the inhibitory effects and metabolic mechanisms of Eucalrobusone C (EC), a novel formyl-phloroglucinol meroterpenoid derivative isolated from Eucalyptus robusta, on Tumour Necrosis Factor-α (TNF-α)-induced rheumatoid arthritis fibroblast-like synoviocytes (RA-FLSs). EC was extracted and purified, with purity confirmed using 1H Nuclear Magnetic Resonance Spectrum (NMR) at 400 MHz. RA-FLSs were exposed to varying concentrations of EC, followed by comprehensive assessment including CCK8 assay for cell proliferation, flow cytometry for cell death, and Transwell assay for migration and invasion capacity. Metabolomic profiling employed Ultra-High Performance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry (UHPLC-Q-TOF MS), integrated with multivariate statistical analysis and bioinformatics tools to identify metabolic alterations. Results indicated that EC suppressed RA-FLS proliferation in a time- and concentration-dependent manner, significantly enhanced apoptosis, and inhibited cell migration and invasion. Metabolomics analysis detected 898 metabolites, with 112 upregulated and 67 downregulated in EC-treated groups compared to TNF-α-induced controls. Key differentially expressed metabolites were enriched in pathways including ABC transporters, neuroactive ligand-receptor interactions, protein digestion and absorption, and cAMP signalling. These findings suggest that EC exerts anti-rheumatic effects by modulating these metabolic pathways, offering potential as a therapeutic agent for RA management.

#2

Vanillin cross-linked chitosan gelatin membrane for potential hemodialysis applications.

International journal of biological macromolecules2026 Mar

End-stage renal disease (ESRD) causes the buildup of metabolic waste in the body, requiring hemodialysis to replace the kidneys' filtering function. The main challenge in hemodialysis is the membrane's effectiveness, which is often limited by hemocompatibility issues. Therefore, improving membrane materials to enhance hemocompatibility and remove uremic toxins remains a key focus of research. In this study, we used modified natural polymers as materials for hemodialysis membranes. Our goal was to develop chitosan (Cs)-based membranes crosslinked with vanillin (Va) and blended with gelatin (Gel) to improve morphology, transport performance, and hemocompatibility. The membrane showed increased porosity at 78.21%, a higher swelling capacity of 36%, and improved water absorption at 89.63%. It also enhanced the transport of creatinine by 92.35% and urea by 61.01%, while demonstrating an enhanced hydrophilicity of 45.89%. Hemocompatibility tests showed significant improvements, including reduced platelet adhesion, lower hemolysis rates (<2%), and prolonged clotting times compared to unmodified Cs membranes, confirming enhanced blood compatibility. These results position the chitosan/vanillin/gelatin (CVG) membrane as a promising candidate for effective hemodialysis applications.

#3

PPAR-γ Activation Alleviates Intestinal Dysfunction and Lactose Malabsorption in Experimental Food Allergy Rats.

Nutrients2026 Feb 16

Food allergy-induced intestinal inflammation can impair lactose digestion and absorption by damaging the epithelium, leading to secondary lactase deficiency with no effective treatments. The immunometabolism nuclear receptor PPAR-γ regulates gut epithelial function and nutrient absorption. This study aimed to determine whether PPAR-γ activation can preserve lactose digestion and absorption during allergic inflammation and to elucidate the underlying mechanisms. In an ovalbumin-sensitized Brown Norway rat model of food allergy, animals were treated with either the PPAR-γ agonist rosiglitazone or the antagonist GW9662. Lactose absorption was assessed by in vivo lactose tolerance tests (blood glucose monitoring) and intestinal transit measurements. Jejunal tissues were analyzed for lactase gene expression, lactase enzyme activity, and SGLT1/GLUT2 transporter levels. Allergic rats exhibited reduced weight gain, delayed intestinal transit, and lactose malabsorption (lower blood glucose after lactose challenge), accompanied by sharply decreased jejunal lactase mRNA, enzyme activity, and SGLT1/GLUT2 levels. Rosiglitazone treatment restored intestinal PPAR-γ expression and markedly improved lactose absorption, normalizing the lactose tolerance curve. Rosiglitazone also increased lactase gene expression and enzyme activity, and upregulated SGLT1 levels. In contrast, PPAR-γ inhibition with GW9662 further reduced lactase and transporter levels and failed to improve absorption. PPAR-γ signaling maintains intestinal lactose digestive capacity of rats during allergic inflammation by sustaining lactase production and monosaccharide transporter expression. Our findings verify an immunometabolism mechanism linking nuclear receptor activation to enhanced nutrient absorption and highlight PPAR-γ agonism as a promising therapeutic strategy to alleviate food allergy-associated lactose malabsorption.

#4

Alternative methods for pharmacological research on the action mechanisms of natural products used in the treatment of type 2 diabetes: a systematic review.

Frontiers in pharmacology2026

Type 2 diabetes (T2D) is a complex metabolic disorder characterized by alterations in multiple pathways of carbohydrate and lipid metabolism. Due to the involvement of a network of dysfunctional enzymes contributing to hyperglycemia, ethnopharmacological research has increasingly focused on identifying new drugs that can improve clinical outcomes. In this context, animal models have remained essential for evaluating naturally occurring molecules with potential hypoglycemic effects. However, the scientific community has recently emphasized the need for alternatives to animal use in biomedical research. This review aims to highlight the alternative approaches employed in recent years to discover natural products with therapeutic potential for T2D, emphasizing the most relevant mechanisms of action and pharmacological targets. A systematic search of original articles published between 2019 and 2024 in the PubMed, Scopus, and Web of Science databases identified nine key mechanisms: inhibition of carbohydrate breakdown, modulation of glucose absorption and uptake, enhancement of glucose storage, suppression of glucose production, targeting insulin resistance factors, insulin sensitization, β-cell protection, improvement of lipid metabolism, and sirtuin modulation. During this period, approximately 45% of the studies employed predominantly in vitro approaches involving enzymes, transporters, and receptors central to the pathophysiology of T2D, while in silico studies displaced in vivo studies, increasing their percentage from 16% to 36% in the last year. This review presents a new classification of action mechanisms and compiles the most representative types of assays that have been carried out in recent years to address the most studied pharmacological targets. Therefore, it is expected that this review serves as a foundation for future investigations into underexplored mechanisms particularly insulin sensitization and pancreatic β-cell preservation that may offer greater therapeutic impact.

#5

Overcoming mucus trapping by engineering PEGylated self-nanoemulsions for enhanced oral absorption of a novel AMPK activator.

International journal of pharmaceutics2026 Mar 25

D100B is a first-in-class small-molecule activator of AMP-activated protein kinase (AMPK) that specifically targets the lysosomal pool, enabling precise metabolic regulation with lower systemic toxicity. Despite its favorable solubility and stability, D100B exhibits extremely poor oral bioavailability due to strong mucoadhesion and extensive retention within the intestinal mucus. Electrostatic and hydrophobic interactions between D100B and mucin were found to severely hinder its diffusion and epithelial absorption. To overcome this limitation, a PEGylated self-nanoemulsifying system (PSNE) was developed to reduce mucin binding and enhance mucus penetration. The optimized PSNE displayed uniform nanoscale droplets, sustained drug release, and significantly improved diffusion in simulated mucus. In Caco-2/HT29-MTX co-culture monolayers, PSNE significantly enhanced epithelial transport, while pharmacokinetic evaluation demonstrated a 2.66-fold increase in oral bioavailability compared with the unformulated drug. Overall, this study establishes a mucus-barrier-focused formulation strategy that may be applicable for improving the oral delivery of amphiphilic compounds whose absorption is compromised by mucus-mediated retention.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 200

2026

Novel anti-rheumatic potential of Eucalrobusone C: inhibition of rheumatoid arthritis fibroblast-like synoviocytes and metabolic reprogramming.

Artificial cells, nanomedicine, and biotechnology
2026

Vanillin cross-linked chitosan gelatin membrane for potential hemodialysis applications.

International journal of biological macromolecules
2026

PPAR-γ Activation Alleviates Intestinal Dysfunction and Lactose Malabsorption in Experimental Food Allergy Rats.

Nutrients
2026

Alternative methods for pharmacological research on the action mechanisms of natural products used in the treatment of type 2 diabetes: a systematic review.

Frontiers in pharmacology
2026

Overcoming mucus trapping by engineering PEGylated self-nanoemulsions for enhanced oral absorption of a novel AMPK activator.

International journal of pharmaceutics
2026

Transcriptomics reveals the temporal responses of sea cucumber (Apostichopus japonicus) to the challenge by bacterial peptidoglycans.

Comparative biochemistry and physiology. Part D, Genomics &amp; proteomics
2026

Highly Ca2+-permeable transient receptor potential vanilloid 6 contributes to the protection against colitis by regulating epithelial barrier function.

American journal of physiology. Gastrointestinal and liver physiology
2026

Epithelial ion transport in spring-lengthened jejunum in a porcine model.

Journal of pediatric surgery
2026

Effect of proinflammatory cytokines on intestinal drug transporters in human enteroid monolayers.

Drug metabolism and disposition: the biological fate of chemicals
2025

Mechanisms and Repair of Skin Barrier Dysfunction: The TLC Strategy.

International journal of dermatology
2026

Flax lignan-fortified nanoemulsions potentiate the conversion of α-linolenic acid to n-3 LCPUFAs: cumulative metabolic patterns in non-fasting mice.

Food &amp; function
2026

Lacticaseibacillus rhamnosus alleviates hyperuricemia by restricting intestinal nucleoside absorption.

Food &amp; function
2026

Chitosan-Derived Carbon Dots Enhance Root Rot Resistance in Isatis Tinctoria L. by Enhancing Plant Defense Responses.

Small (Weinheim an der Bergstrasse, Germany)
2025

Spermidine Prevents Polarity Loss of Absorptive Enterocytes in Jejunum of Lipopolysaccharide-Challenged Mice via 4D-DIA Proteomics Analysis.

Journal of proteome research
2025

Assessment of distinct effects of Parinari curatellifolia Planch.ex Benth Ethanolic leaf extract on glucose transport in different cell types.

PeerJ
2025

Antihyperuricemic Effects of Cornus officinalis Extract via URAT1 Regulation and Renoprotective Mechanisms.

International journal of molecular sciences
2025

Factors Affecting Circulating Phytosterol Levels: Toward an Integrated Understanding of Atherogenicity and Atheroprotection by Dietary and Circulating Phytosterols.

Current atherosclerosis reports
2026

A 3D microfluidic model for preclinical drug permeation studies: Advancing validation of skin-on-chip technology.

Journal of pharmaceutical and biomedical analysis
2026

Oral Administration of Trifluoroacetyl Chitosan-Encapsulated Redshifted Immunofluorophore for NIR-II Bioimaging of Colorectal Metastases.

Advanced healthcare materials
2025

Functional and morphological characterisation of human colonoid-derived monolayers under inflammatory conditions.

International journal of pharmaceutics
2025

Glucose transports in the ileum: mechanism, regulation and physiological role of ileal glucose absorption.

Biochemical and biophysical research communications
2025

Pathophysiology of the Neutropenia of GSDIb and G6PC3 Deficiency: Origin, Metabolism and Elimination of 1,5-Anhydroglucitol.

Journal of inherited metabolic disease
2025

Population Pharmacokinetic Modeling of Canagliflozin in Advanced Chronic Kidney Disease.

Clinical pharmacokinetics
2025

Sotagliflozin Reduces Glucose Absorption and Improves Ultrafiltration in a Rat Model of Chronic Peritoneal Exposure to High-Glucose Dialysate.

Blood purification
2025

Biopharmaceutical Factors Involved in the Disposition of Mycophenolic Acid: A Comprehensive Review of ADME Properties and Their Potential Impact on Mycophenolic Acid Plasma Exposure.

Current drug metabolism
2025

The Adipose Tissue-Derived Secretome (ADS) in Obesity Uniquely Regulates the Na-Glucose Transporter SGLT1 in Intestinal Epithelial Cells.

Cells
2025

Rosuvastatin PBPK Modeling: Incorporating Liver Concentrations and Effects of Ethnicity, Genetic Polymorphisms, Lactone Formation, DDI and Pregnancy.

CPT: pharmacometrics &amp; systems pharmacology
2025

Isolated thrombocytopenia as an atypical presentation of sitosterolemia in a school-aged child.

Journal of clinical lipidology
2025

High-Fructose-Induced Salt-Sensitive Hypertension: The Potential Benefit of SGLT4 or SGLT5 Modulation.

Nutrients
2025

A novel exploration of the extraction of sea cucumber glycoproteins and their potential mechanism in prediabetes intervention.

Food research international (Ottawa, Ont.)
2025

Aloe vera polysaccharides mitigate high-fat high-cholesterol diet-induced atherosclerosis in ApoE-/- mice via regulation of lipid metabolism and gut microbiota.

Food &amp; function
2025

Sitosterolemia caused by compound heterozygosis of 2 allelic variants in the ABCG5 gene-21 years of follow-up.

Journal of clinical lipidology
2025

A new link between insulinoma and congenital glucose-galactose malabsorption.

Endocrine oncology (Bristol, England)
2025

Unlocking the Potential of Sotagliflozin in Diabetes Mellitus targeting SGLT 1 & SGLT 2: A Comprehensive Review.

Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
2025

Sustained release of betamethasone from solid lipid nanoparticles loaded polymeric hydrogels with natural emollient: One step closer to effective topical therapy for atopic dermatitis.

Journal of pharmaceutical sciences
2025

Characteristics and Functions of Different Intestinal Segments in Juvenile Greater Amberjack (Seriola dumerili).

Animals : an open access journal from MDPI
2025

The Metabolic Consequences of Pathogenic Variant in FXYD2 Gene Encoding the Gamma Subunit of Sodium/Potassium-Transporting ATPase in Two Siblings with Sodium-Dependent Defect of Fructose, Galactose and Glucose Renal Reabsorption.

Genes
2025

Gly-βMCA modulates bile acid metabolism to reduce hepatobiliary injury in Mdr2 KO mice.

American journal of physiology. Gastrointestinal and liver physiology
2025

Pharmacokinetics and pharmacodynamics of empagliflozin in paediatric patients aged 10-17 years with type 2 diabetes mellitus.

British journal of clinical pharmacology
2025

Integrated transcriptomics and metabolomics unravel the key metabolic pathways involved in the therapeutic mechanism of Salvianic acid A against hepatic fibrosis.

Toxicology and applied pharmacology
2025

Cinnamaldehyde enhances the intervention effect of puerarin on stroke from the perspectives of pharmacokinetics and pharmacodynamics.

European journal of pharmacology
2026

Epigallocatechin gallate prevents and alleviates type 2 diabetes mellitus (T2DM) through gut microbiota and multi-organ interactions in Wistar healthy rats and GK T2DM rats.

Journal of advanced research
2025

Impact of tailored dietary interventions on suspected carbohydrate intolerance patients based on genetic testing.

Nutricion hospitalaria
2025

Canagliflozin: A Comprehensive Review of Advances in Preclinical Research.

Drug research
2025

Impact of SGLT2 Inhibitors on Magnesium in Kidney Transplant Patients with and Without Diabetes.

International journal of molecular sciences
2025

Expression, Function, and Regulation of ABCG2 on the Intestinal Epithelial Barrier Permeability.

Current drug metabolism
2025

Critical Importance of Iron Saturation in Lactoferrin: Effects on Biological Activity, Nutritional Functions, and Applications.

Journal of agricultural and food chemistry
2025

ASK1 limits kidney glucose reabsorption, growth, and mid-late proximal tubule KIM-1 induction when diabetes and Western diet are combined with SGLT2 inhibition.

American journal of physiology. Renal physiology
2025

Sulfo-N-Succinimidyl Oleate Sodium as CD36 Inhibitor: Dose Optimization and Its Effects on FFA Uptake, Inflammation, and ER Stress in HepG2 Cells.

Journal of biochemical and molecular toxicology
2025

Hypothyroidism impairs the circadian rhythmicity of clock genes and proteins involved in gut nutrient absorption in female mice.

Frontiers in physiology
2025

Intestinal Gastrin/CCKBR Axis Protects against Type 2 Diabetes by Reducing Intestinal Glucose Absorption through the PI3K/Akt/eIF4B Signaling Pathway.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2025

Apabetalone alleviates ligature-induced periodontitis by inhibiting M1 macrophage polarization via an immunometabolic shift.

International immunopharmacology
2025

β-Glucan-based superabsorbent hydrogel ameliorates obesity-associated metabolic disorders via delaying gastric emptying, improving intestinal barrier function, and modulating gut microbiota.

International journal of biological macromolecules
2025

High fructose rewires gut glucose sensing via glucagon-like peptide 2 to impair metabolic regulation in mice.

Molecular metabolism
2024

The impact of solute carrier proteins on disrupting substance regulation in metabolic disorders: insights and clinical applications.

Frontiers in pharmacology
2025

Protein abundance of drug transporters and drug-metabolizing enzymes in paired healthy and tumor tissue from colorectal cancer patients.

International journal of pharmaceutics
2025

Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling.

Clinical pharmacokinetics
2025

Major facility superfamily sugar transporter protein SsMFSST1 regulates Sporisorium scitamineum mating, pathogenicity, and sugar transport/absorption.

Microbiology spectrum
2025

Nanoencapsulation of vitamin B2 using chitosan-modified poly(lactic-co-glycolic acid) nanoparticles: Synthesis, characterization, and in vitro studies on simulated gastrointestinal stability and delivery.

Journal of food science
2025

An oral liraglutide nanomicelle formulation conferring reduced insulin-resistance and long-term hypoglycemic and lipid metabolic benefits.

Journal of controlled release : official journal of the Controlled Release Society
2025

Conversion of α-linolenic acid into n-3 long-chain polyunsaturated fatty acids: bioavailability and dietary regulation.

Critical reviews in food science and nutrition
2024

Regulation of lipid storage and inflammation in the liver by CEACAM1.

European journal of clinical investigation
2024

An Amorphous Solid Dispersion of Baicalin and its Oral Therapeutic Effect on Ulcerative Colitis.

Pharmaceutical research
2024

Ginsenoside Rb1 affects mitochondrial Ca2+ transport and inhibits fat deposition and fibrosis by regulating the wnt signaling pathway to treat rotator cuff tears via docking with SFRP1.

Molecular medicine (Cambridge, Mass.)
2024

Capturing ultrafast energy flow of a heme protein in crowded milieu.

Physical chemistry chemical physics : PCCP
2025

Identification of a homozygous variant in ABCG5 by panel sequencing in a Pakistani family with sitosterolemia: Genotype-phenotype correlation and management considerations.

Journal of clinical lipidology
2024

Role of Gpcpd1 in intestinal alpha-glycerophosphocholine metabolism and trimethylamine N-oxide production.

The Journal of biological chemistry
2024

Intestinal transport of organic food compounds and drugs: A scoping review on the alterations observed in chronic kidney disease.

Clinical nutrition ESPEN
2024

Lactobacillus gasseri BNR17 and Limosilactobacillus fermentum ABF21069 Ameliorate High Sucrose-Induced Obesity and Fatty Liver via Exopolysaccharide Production and β-oxidation.

Journal of microbiology (Seoul, Korea)
2024

ATP-binding cassette transporter TaABCG2 contributes to Fusarium head blight resistance by mediating salicylic acid transport in wheat.

Molecular plant pathology
2024

Carnitine traffic and human fertility.

Biochemical pharmacology
2025

Evaluation of plasma phytosterols in sitosterolemia, their kindreds and hyperlipidemia subjects.

Journal of clinical lipidology
2024

The pharmacokinetics of dabigatran in a rat model of hyperlipidaemia induced by poloxamer 407.

Xenobiotica; the fate of foreign compounds in biological systems
2024

Bacterial lipopolysaccharide inhibits free thiamin uptake along the intestinal tract via interference with membrane expression of thiamin transporters 1 and 2.

American journal of physiology. Cell physiology
2024

Protective effect of walnut active peptide against dextran sulfate sodium-induced colitis in mice based on untargeted metabolomics.

International immunopharmacology
2024

Highly Potent and Intestine Specific P-Glycoprotein Inhibitor to Enable Oral Delivery of Taxol.

Angewandte Chemie (International ed. in English)
2024

Nuclear Receptor Corepressors NCOR1 and SMRT Regulate Metabolism via Intestinal Regulation of Carbohydrate Transport.

Endocrinology
2024

Plasma, brain and spinal cord concentrations of caffeine are reduced in the SOD1G93A mouse model of amyotrophic lateral sclerosis following oral administration.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
2024

Intestinal fructose transporters GLUT5 and GLUT2 in children and adolescents with obesity and metabolic disorders.

Advances in medical sciences
2024

Can one long peritoneal dwell with icodextrin replace two short dwells with glucose?

Frontiers in physiology
2024

Sucrose Solution Ingestion Exacerbates Dinitrofluorobenzene-Induced Allergic Contact Dermatitis in Rats.

Nutrients
2024

Mitochondria UPR stimulation by pelargonidin-3-glucoside contributes to ameliorating lipid accumulation under copper exposure.

The Science of the total environment
2024

Late diagnosis of sitosterolemia in an adult case with unexplained hemolytic anemia.

International journal of laboratory hematology
2024

Oral sericin ameliorates type 2 diabetes through passive intestinal and bypass transport into the systemic circulation.

Journal of ethnopharmacology
2024

Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis.

International journal of pharmaceutics
2024

Diet management in congenital diarrheas and enteropathies - general concepts and disease-specific approach, a narrative review.

The American journal of clinical nutrition
2024

Genetic causes of hypophosphatemia.

Minerva medica
2024

The inhibitory effects of endophytic metabolites on glycated proteins under non-communicable disease conditions: A review.

International journal of biological macromolecules
2026

SGLT-2 Inhibitors: Focus on Dapagliflozin.

Cardiology in review
2024

Associations of Dietary Cholesterol Consumption With Incident Diabetes and Cardiovascular Disease: The Role of Genetic Variability in Cholesterol Absorption and Disease Predisposition.

Diabetes care
2024

Understanding adefovir pharmacokinetics as a component of a transporter phenotyping cocktail.

European journal of clinical pharmacology
2024

Platelet proteomic profiling in sitosterolemia suggests thrombocytopenia is driven by lipid disorder and not platelet aberrations.

Blood advances
2024

Mechanisms of Dangua Fang in multi-target and multi-method regulation of glycolipid metabolism based on phosphoproteomics.

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
2024

Sporisorium reilianum polysaccharides improve DSS-induced ulcerative colitis by regulating intestinal barrier function and metabolites.

International journal of biological macromolecules
2024

ABCG2 polymorphisms and susceptibility to ARV-associated hepatotoxicity.

Molecular genetics &amp; genomic medicine
2024

The Role of Anthocyanins in Alleviating Intestinal Diseases: A Mini Review.

Journal of agricultural and food chemistry
2024

Family sitosterolemia: report of two cases in Colombia.

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
2024

Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research.

Stem cell research &amp; therapy
2024

Effects of sodium-glucose co-transporter 2 inhibitors on ultrafiltration in patients with peritoneal dialysis: a protocol for a randomized, double-blind, placebo-controlled, crossover trial (EMPOWERED).

Clinical and experimental nephrology
2024

Enhanced brain distribution of Ginsenoside F1 via intranasal administration in combination with absorption enhancers.

International journal of pharmaceutics
2025

Identification of phytocompounds as potent inhibitors of sodium/glucose cotransporter-2 leading to diabetes treatment.

Journal of biomolecular structure &amp; dynamics
2024

Important nutrient sources and carbohydrate metabolism patterns in the growth and development of spargana.

Parasites &amp; vectors
2024

Vitamin K (Menadione)-incorporated chitosan/alginate hydrogel as a novel product for periorbital hyperpigmentation.

Journal of biomaterials science. Polymer edition
2024

Increased Intestinal Permeability and Decreased Resiliency of the Intestinal Barrier in Alcoholic Liver Disease.

Clinical and translational gastroenterology
2024

Traditional Chinese Medicine formula Dai-Zong-Fang alleviating hepatic steatosis in db/db mice via gut microbiota modulation.

Frontiers in pharmacology
2024

D-ribose metabolic disorder and diabetes mellitus.

Molecular biology reports
2024

The association of ABCB1 gene polymorphism with clinical response to carbamazepine monotherapy in patients with epilepsy.

Molecular biology reports
2024

Hydrogel-encapsulated medium chain lipid-modified zeolite imidazole framework-90 as a promising platform for oral delivery of proteins.

Journal of controlled release : official journal of the Controlled Release Society
2023

An overview of the role of Niemann-pick C1 (NPC1) in viral infections and inhibition of viral infections through NPC1 inhibitor.

Cell communication and signaling : CCS
2024

A physiologically based toxicokinetic model of P-glycoprotein transporter-mediated placenta perfusion of dexamethasone in the pregnant rat.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
2024

A Model-Based 13C-Sucrose Breath Test Diagnostic for Gut Function Disorders Characterized by a Loss of Sucrase-Isomaltase Enzymatic Activity.

The Journal of nutrition
2024

Therapeutic effect of yinchenhao decoction on cholelithiasis via mucin in the gallbladder and intestine.

Fitoterapia
2023

Integration of 16S rRNA gene sequencing and LC/MS-based metabolomic analysis of early biomarkers of acute ischaemic stroke in Tibetan miniature pigs.

Journal of microbiological methods
2024

SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus.

Current medicinal chemistry
2023

Synergistic effect of lactoferrin and osteopontin on intestinal barrier injury.

International journal of biological macromolecules
2023

High-Carbohydrate Diet Consumption Poses a More Severe Liver Cholesterol Deposition than a High-Fat and High-Calorie Diet in Mice.

International journal of molecular sciences
2024

Promoting oral absorption of Panax notoginseng saponins via thiolated trimethyl chitosan and wheat germ agglutinin-modified nanoformulation.

Drug delivery and translational research
2023

Bone marrow mesenchymal stem cells-derived exosomes mediated delivery of tetramethylpyrazine attenuate cerebral ischemic injury.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
2023

Serum and urine metabolomics study revealed the amelioration of Gynura bicolor extract on high fat diet-fed and streptozotocin-induced type 2 diabetic mice based on UHPLC-MS/MS.

Journal of pharmaceutical and biomedical analysis
2023

Protective Effects of Melatonin in High-Fat Diet-Induced Hepatic Steatosis via Decreased Intestinal Lipid Absorption and Hepatic Cholesterol Synthesis.

Endocrinology and metabolism (Seoul, Korea)
2023

Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, in-vitro, in silico, and in-vivo study.

Drug delivery
2023

Taurocholate uptake by Caco-2 cells is inhibited by pro-inflammatory cytokines and butyrate.

Cytokine
2023

Aquaporin-4 Deficiency is Associated with Cognitive Impairment and Alterations in astrocyte-neuron Lactate Shuttle.

Molecular neurobiology
2024

Screening of anti-functional dyspepsia compounds in Cynanchum auriculatum: A spectrum-effect relationship analysis, and ATP-binding cassette transporters inhibitor evaluation.

Journal of ethnopharmacology
2023

Dietary diosgenin transcriptionally down-regulated intestinal NPC1L1 expression to prevent cholesterol gallstone formation in mice.

Journal of biomedical science
2023

In Vitro Interaction of Tetrahydrouridine with Key Human Nucleoside Transporters.

Journal of pharmaceutical sciences
2023

Mendelian randomisation reveals Sodium-glucose Cotransporter-1 inhibition's potential in reducing Non-Alcoholic Fatty Liver Disease risk.

European journal of endocrinology
2023

Enhancing the Impact of Chemotherapy on Ewing Sarcoma Cells through Combination with Cold Physical Plasma.

International journal of molecular sciences
2023

The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy.

Genes
2023

High Fructose Corn Syrup Accelerates Kidney Disease and Mortality in Obese Mice with Metabolic Syndrome.

Biomolecules
2023

Downregulation of intestinal multidrug resistance transporter 1 in obese mice: Effect on its barrier function and role of TNF-α receptor 1 signaling.

Nutrition (Burbank, Los Angeles County, Calif.)
2023

The SWGEDWGEIW from Soybean Peptides Reduces Insulin Resistance in 3T3-L1 Adipocytes by Activating p-Akt/GLUT4 Signaling Pathway.

Molecules (Basel, Switzerland)
2023

The Influence of Alcohol Consumption on Intestinal Nutrient Absorption: A Comprehensive Review.

Nutrients
2023

Antioxidant effects of silver nanoparticles obtained by green synthesis from the aqueous extract of Eryngium carlinae on the brain mitochondria of streptozotocin-induced diabetic rats.

Journal of bioenergetics and biomembranes
2023

Linagliptin exacerbates heart failure due to energy deficiency via downregulation of glucose utilization and absorption in a mouse model.

European journal of pharmacology
2023

Dietary advanced glycation end products (dAGEs): An insight between modern diet and health.

Food chemistry
2023

Citric Acid Enhances the Activities of Astilbin on Psoriasis via Down-Regulation of P-Glycoprotein.

Molecular pharmaceutics
2023

Absorption and Transport Mechanism of Red Meat-Derived N-glycolylneuraminic Acid and Its Damage to Intestinal Barrier Function through the NF-κB Signaling Pathway.

Toxins
2023

Oral Exposure to Polystyrene Microplastics of Mice on a Normal or High-Fat Diet and Intestinal and Metabolic Outcomes.

Environmental health perspectives
2023

[Evaluation and Clarification of Enterohepatic Interactions in Pharmacokinetics].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
2023

Ferulic acid supplementation alleviates hyperuricemia in high-fructose/fat diet-fed rats via promoting uric acid excretion and mediating the gut microbiota.

Food &amp; function
2023

Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape.

Expert review of clinical pharmacology
2022

Bile acids and microbes in metabolic disease.

World journal of gastroenterology
2023

Fibroblast growth factor 21 as a potential master regulator in metabolic disorders.

American journal of physiology. Endocrinology and metabolism
2022

Enhancing Mechanisms of the Plant Growth-Promoting Bacterial Strain Brevibacillus sp. SR-9 on Cadmium Enrichment in Sweet Sorghum by Metagenomic and Transcriptomic Analysis.

International journal of environmental research and public health
2022

Carbohydrate malabsorption in anorexia nervosa: a systematic review.

Journal of eating disorders
2023

Activating transcription factor 3, glucolipid metabolism, and metabolic diseases.

Journal of molecular cell biology
2022

Odevixibat: an investigational inhibitor of the ileal bile acid transporter (IBAT) for the treatment of biliary atresia.

Expert opinion on investigational drugs
2022

Dietary Polyphenols and In Vitro Intestinal Fructose Uptake and Transport: A Systematic Literature Review.

International journal of molecular sciences
2022

The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1.

Kidney and dialysis
2022

Regulation of glucose transporter-4 intervention with S. saman leaves extract in streptozotocin-induced diabetic rats.

Journal of diabetes and its complications
2022

Development of Paeonol Liposomes: Design, Optimization, in vitro and in vivo Evaluation.

International journal of nanomedicine
2023

Rhizoctonia solani transcriptional activator interacts with rice WRKY53 and grassy tiller 1 to activate SWEET transporters for nutrition.

Journal of advanced research
2022

Iron and iron-related proteins in alcohol consumers: cellular and clinical aspects.

Journal of molecular medicine (Berlin, Germany)
2023

Sweetly Improving Sugars? Reviewing Cinnamon's Effects on Blood Glucose.

Journal of medicinal food
2022

α-Tocopherol Pharmacokinetics in Adults with Cystic Fibrosis: Benefits of Supplemental Vitamin C Administration.

Nutrients
2022

Selective Fluorescent Probes for High-Throughput Functional Diagnostics of the Human Multidrug Transporter P-Glycoprotein (ABCB1).

International journal of molecular sciences
2022

Population-based meta-analysis and gene-set enrichment identifies FXR/RXR pathway as common to fatty liver disease and serum lipids.

Hepatology communications
2022

Research progress on natural β-glucan in intestinal diseases.

International journal of biological macromolecules
2022

Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs.

Clinical pharmacokinetics
2022

Fe3+ opposes the 1,25(OH)2D3-induced calcium transport across intestinal epithelium-like Caco-2 monolayer in the presence or absence of ascorbic acid.

PloS one
2022

Hijacking the intrinsic vitamin B12 pathway for the oral delivery of nanoparticles, resulting in enhanced in vivo anti-leishmanial activity.

Biomaterials science
2022

Identification of N-Glycoproteins of Knee Cartilage from Adult Osteoarthritis and Kashin-Beck Disease Based on Quantitative Glycoproteomics, Compared with Normal Control Cartilage.

Cells
2022

Aristolochic acid-induced nephropathy is attenuated in mice lacking the neutral amino acid transporter B0AT1 (Slc6a19).

American journal of physiology. Renal physiology
2022

Synthesis of 2-Acetamido-1,3,4-Tri-O-Acetyl-2-Deoxy-D-Mannopyranose -6-Phosphate Prodrugs as Potential Therapeutic Agents.

Current protocols
2023

Increased glucose influx and glycogenesis in lung cancer cells surviving after irradiation.

International journal of radiation biology
2022

Comparative Effects of Allulose, Fructose, and Glucose on the Small Intestine.

Nutrients
2022

The Deficiency of SCARB2/LIMP-2 Impairs Metabolism via Disrupted mTORC1-Dependent Mitochondrial OXPHOS.

International journal of molecular sciences
2022

Intestinal lipid absorption and transport in type 2 diabetes.

Diabetologia
2022

Metabolism toxicity and susceptibility of decabromodiphenyl ether (BDE-209) exposure on BRL cells with insulin resistance.

Environmental science and pollution research international
2022

Altered fecal microbial and metabolic profile reveals potential mechanisms underlying iron deficiency anemia in pregnant women in China.

Bosnian journal of basic medical sciences
2022

Absorption characteristics of ilexgenin A and ilexsaponin B1 in human umbilical vein endothelial cells after administration of the total triterpenoid saponins from Ilex pubescens.

Biomedical chromatography : BMC
2022

Diabetes mellitus and diabetic foot ulcer: Etiology, biochemical and molecular based treatment strategies via gene and nanotherapy.

Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie
2023

Effects of different dietary protein levels on intestinal aquaporins in weaned piglets.

Journal of animal physiology and animal nutrition
2022

Congenital Rare Diseases Causing Persistent Diarrhea in the Newborn: A Single Center Experience.

Zeitschrift fur Geburtshilfe und Neonatologie
2022

Great Northern Beans (Phaseolus vulgaris L.) Lower Cholesterol in Hamsters Fed a High-Saturated-Fat Diet.

The Journal of nutrition
2022

Transport mechanism of hydroxy-propyl-beta-cyclodextrin modified solid lipid nanoparticles across human epithelial cells for the oral absorption of antileishmanial drugs.

Biochimica et biophysica acta. General subjects
2022

The Microbiome and Uremic Solutes.

Toxins
2022

Vitamin B12 absorption and malabsorption.

Vitamins and hormones
2023

Hypoglycemic bioactivity of anthocyanins: A review on proposed targets and potential signaling pathways.

Critical reviews in food science and nutrition
2022

Effects of an SGLT Inhibitor on the Production, Toxicity, and Elimination of Gut-Derived Uremic Toxins: A Call for Additional Evidence.

Toxins
2022

Capsaicin inhibits intestinal Cl- secretion and promotes Na+ absorption by blocking TRPV4 channels in healthy and colitic mice.

The Journal of biological chemistry
2022

Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel.

European journal of medicinal chemistry
2022

Elucidation of the Transport Mechanism of Puerarin and Gastrodin and Their Interaction on the Absorption in a Caco-2 Cell Monolayer Model.

Molecules (Basel, Switzerland)
2022

The Crowded Uterine Horn Mouse Model for Examining Postnatal Metabolic Consequences of Intrauterine Growth Restriction vs. Macrosomia in Siblings.

Metabolites
2022

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.

Clinical pharmacology and therapeutics
2022

Common variant p.D19H of the hepatobiliary sterol transporter ABCG8 increases the risk of gallstones in children.

Liver international : official journal of the International Association for the Study of the Liver
2023

Dietary proanthocyanidins on gastrointestinal health and the interactions with gut microbiota.

Critical reviews in food science and nutrition
2021

Naturally Occurring SGLT2 Inhibitors: A Review.

Advances in experimental medicine and biology
2021

Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation.

Cells
2021

SGLT-1-specific inhibition ameliorates renal failure and alters the gut microbial community in mice with adenine-induced renal failure.

Physiological reports
2021

Design Strategy for a Hydroxide-Triggered pH-Responsive Hydrogel as a Mucoadhesive Barrier to Prevent Metabolism Disorders.

ACS applied materials &amp; interfaces
2021

Drosophila Solute Carrier 5A5 Regulates Systemic Glucose Homeostasis by Mediating Glucose Absorption in the Midgut.

International journal of molecular sciences
2021

Revisiting definition and assessment of intestinal trans-epithelial passage.

Cellular and molecular life sciences : CMLS
2022

Lipopolysaccharides derived from gram-negative bacterial pool of human gut microbiota promote inflammation and obesity development.

International reviews of immunology
2021

Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway.

European journal of pharmacology
2022

Recent advances in riboflavin transporter RFVT and its genetic disease.

Pharmacology &amp; therapeutics
2021

Hnf4g invalidation prevents diet-induced obesity via intestinal lipid malabsorption.

The Journal of endocrinology
2022

Hemochromatosis classification: update and recommendations by the BIOIRON Society.

Blood
2021

A new mechanism of POCD caused by sevoflurane in mice: cognitive impairment induced by cross-dysfunction of iron and glucose metabolism.

Aging

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Alteração da absorção e transporte de carboidratos.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Alteração da absorção e transporte de carboidratos

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Novel anti-rheumatic potential of Eucalrobusone C: inhibition of rheumatoid arthritis fibroblast-like synoviocytes and metabolic reprogramming.
    Artificial cells, nanomedicine, and biotechnology· 2026· PMID 41842697mais citado
  2. Vanillin cross-linked chitosan gelatin membrane for potential hemodialysis applications.
    International journal of biological macromolecules· 2026· PMID 41763427mais citado
  3. PPAR-&#x3b3; Activation Alleviates Intestinal Dysfunction and Lactose Malabsorption in Experimental Food Allergy Rats.
    Nutrients· 2026· PMID 41754171mais citado
  4. Alternative methods for pharmacological research on the action mechanisms of natural products used in the treatment of type 2 diabetes: a systematic review.
    Frontiers in pharmacology· 2026· PMID 41743124mais citado
  5. Overcoming mucus trapping by engineering PEGylated self-nanoemulsions for enhanced oral absorption of a novel AMPK activator.
    International journal of pharmaceutics· 2026· PMID 41740768mais citado
  6. Epithelial ion transport in spring-lengthened jejunum in a porcine model.
    J Pediatr Surg· 2026· PMID 41423148recente
  7. Effect of proinflammatory cytokines on intestinal drug transporters in human enteroid monolayers.
    Drug Metab Dispos· 2026· PMID 41418738recente
  8. Assessment of distinct effects of Parinari curatellifolia Planch.ex Benth Ethanolic leaf extract on glucose transport in different cell types.
    PeerJ· 2025· PMID 41244198recente
  9. β-Glucan-based superabsorbent hydrogel ameliorates obesity-associated metabolic disorders via delaying gastric emptying, improving intestinal barrier function, and modulating gut microbiota.
    Int J Biol Macromol· 2025· PMID 39933677recente
  10. Major facility superfamily sugar transporter protein SsMFSST1 regulates Sporisorium scitamineum mating, pathogenicity, and sugar transport/absorption.
    Microbiol Spectr· 2025· PMID 39745386recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:309001(Orphanet)
  2. MONDO:0017706(MONDO)
  3. GARD:21313(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q55787291(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Alteração da absorção e transporte de carboidratos
Compêndio · Raras BR

Alteração da absorção e transporte de carboidratos

ORPHA:309001 · MONDO:0017706
CID-11
MedGen
UMLS
C5681069
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades